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Myosins and tropomyosins represent two types of actin filament-associated 
proteins that often work together in contractile and motile processes in the cell. While 
the role of thin filament troponin-tropomyosin complexes in regulating striated muscle 
myosin II is well characterized, the role of tropomyosins in non-muscle myosin 
regulation is not well understood. Fission yeast has recently proved to be a useful model 
with which to study regulation of myosin motors by tropomyosin owing to its tractable 
genetics, well-defined actin cytoskeleton, and established actin biochemistry. 
A hallmark of type V myosins is their processivity – the ability to take multiple 
steps along actin filaments without dissociating.  However, the fission yeast type V 
myosin (Myo52) is a nonprocessive motor whose activity is enhanced by the sole 
fission yeast tropomyosin (Cdc8). The molecular mechanism and physiological 
relevance of tropomyosin-mediated regulation of Myo52 transport was investigated 
using a combination of in vitro and in vivo approaches. Single molecules of Myo52, 
visualized by total internal reflection fluorescence microscopy, moved processively 
only when Cdc8 was present on actin filaments. Small ensembles of Myo52 bound to a 
quantum dot, mimicking the number of motors bound to physiological cargo, also 
required Cdc8 for continuous motion. Although a truncated form of Myo52 that lacked 
a cargo-binding domain failed to support function in vivo, it still underwent actin-
dependent movement to polarized growth sites. This result suggests that truncated 
Myo52 lacking cargo, or single molecules of wild-type Myo52 with small cargoes, can 
undergo processive movement along actin-Cdc8 cables in vivo. These findings outline a 
mechanism by which tropomyosin facilitates sorting of transport to specific actin tracks 
within the cell by switching on myosin processivity. 
To understand the broader implications of actomyosin regulation by 
tropomyosin we examined the role of two mammalian tropomyosins (Tpm3.1 and 
Tpm4.2) recently implicated in cancer cell proliferation and metastasis.  As previously 
observed with Cdc8, Tpm3.1 and Tpm4.2 isoforms significantly enhance non-muscle 
myosin II (Myo2).  Additionally, the mammalian tropomyosins enable Myo52 
processive movement along actin tracks.  In contrast to the positive regulation of Myo2 
and Myo52, Cdc8 and the mammalian tropomyosins potently inhibit skeletal muscle 
myosin II, while having negligible effects on the highly processive mammalian myosin-
Va. Thus, different motor outputs favoring functional specification within the same 
myosin class are possible in the presence of certain tropomyosins.  In support of a 
conserved role for certain tropomyosins in regulating non-muscle actomyosin 
structures, Tpm3.1 rescued normal contractile ring dynamics, cytokinesis, and fission 
yeast cell growth in the absence of functional Cdc8. This work has broad implications 
with regard to regulation of non-muscle and muscle actomyosin function in complex 
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Chapter 1: Introduction 
 
 
The actin cytoskeleton enables eukaryotic cells to respond to developmental and 
environmental cues with diverse processes, including cell motility, cargo transport, 
endocytosis, and cytokinesis.  These processes rely upon the diverse structures that 
comprise the actin cytoskeleton and their interactions with myosin motors.  Actomyosin 
complexes provide both the architecture and the force necessary to accomplish these 
critical tasks.  Migrating cells use actomyosin for the translocation of the cell body and 
the subsequent retraction of the trailing edge (Mitchison et al., 1996).  Myosin motors 
transport cellular components along an elaborate network of actin filaments to meet the 
specific spatial needs of a cell (Sellers et al., 2006).  Cytoplasmic membrane-bound 
actomyosin patches remodel the cell following endocytosis (Kovar et al., 2011) and the 
constricting actomyosin ring facilitates the division of replicating cells during 
cytokinesis (Miller, 2011).  Although actin and myosin are essential for each of these 
processes, they are not sufficient.  Numerous actin-binding proteins (ABPs) are critical 
to form diverse actin structures and for the regulation of myosin motors (dos Remedios 
et al., 2003; Uribe et al., 2009).  It is becoming increasingly clear that the tropomyosin 
family of ABPs plays an important role in the formation of actin structures as well as in 
determining their function (Gunning, Hardeman, et al., 2015; Manstein et al., 2016).  
Tropomyosin has been identified as playing an important role in regulating 
myosin function.  In particular, the role of tropomyosin in regulating muscle myosin has 
been the focus of a considerable number of studies, which have provided extensive 
insights into the mechanism of tropomyosin function (Galinska-Rakoczy et al., 2008; 
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Gordon et al., 2000; Trybus, 1991; Webb, 2003).  However, considerable differences 
exist between actomyosin structures in muscle and nonmuscle cells that indicate a 




 Actin is the most abundantly expressed protein in eukaryotic cells (T. D. 
Pollard, 2016).  Bacteria, archaea, and eukaryotes all express highly functionally related 
forms of actin (Herman, 1993).  The actin population in the cell comprises both globular 
monomers (G-actin) and filamentous polymers (F-actin).  Actin monomers consist of 
375 amino acids with a molecular mass of 42 kDa.  Structurally related to hexokinases, 
sugar kinases and Hsp70, actin is a flat protein that is folded into four subdomains, 
SD1-4.  SD1 and SD3 exhibit a high degree of sequence similarity likely due to a gene 
duplication event (Dominguez et al., 2011).  SD2 and SD4 are small insertions within 
SD1 and SD3, respectively. The sequence spanning residues Gly137 to Ser145 connects 
subdomains SD1 and SD3 and acts as a pivot point within the molecule (von der Ecken 
et al., 2015).  Additionally, this arrangement forms an upper and lower cleft between the 
subdomains SD2 and SD3.  The upper cleft contains an adenine nucleotide-binding 
pocket between SD1 and SD3.  The lower cleft contains the binding site for actin 
subunit interactions required for filament formation, as well as the interaction site for 
most ABPs (von der Ecken et al., 2015) (Figure 1-1). This arrangement causes the 
nucleotide bound at the upper cleft to affect actin polymerization and ABP association.	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 In contrast to the single actin isoform expressed in yeast, mammals express six 
actin isoforms.  Four actin isoforms are expressed exclusively in muscle: α-skeletal, α-
cardiac, α-smooth, and γ-smooth; while β-cytoplasmic and γ-cytoplasmic are 
ubiquitously expressed (Perrin et al., 2010).  Although mammalian actin isoforms are 
highly conserved – having at least 93% sequence identity – there is limited ability to 
replace one isoform with another, indicating the importance of even a relatively small 
fraction of sequence variation to the protein’s function (Gunning, Ghoshdastider, et al., 
2015).  Additionally, to further increase diversity, eukaryotic actin is regulated by a 
Figure 1-1. Structure of the actin molecule.  (A) Ribbon diagram of the actin 
molecule with space-filling ATP (protein data bank [PDB]: 1ATN).  (B) Space-
filling model of actin showing the nucleotide-binding cleft with ATP in situ and 
barbed-end groove. (Modified from Pollard and Earnshaw 2007.)  
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number of post-translational modifications, including phosphorylation, acetylation, and 
methylation (Dominguez & Holmes, 2011).  Methylation of actin His-73 in many 
species regulates stability and interdomain flexibility, while N-terminal acetylation 
enables actomyosin interactions in muscle cells (Terman et al., 2013).  
 
Actin polymerization 
 Actin self-assembles into filaments at physiological salt concentrations in the 
presence of adenosine nucleotides and either Ca2+ or Mg2+ (Chesarone et al., 2009). The 
helical arrangement of actin monomers in the filamentous polymer results in a polarized 
structure.  The polarization was first revealed by the arrowhead-like structure observed 
by electron microscopy when myosin was bound to actin filaments.  This led to the 
naming of the pointed (or minus) and barbed (plus) ends (Huxley, 1963).  Actin 
filament length can be highly dynamic and is determined by the ratios between addition 
and removal of actin subunits at the pointed and barbed ends (Figure 2-1). Diffusion 
limited subunit addition is slightly faster at the barbed end while subunit disassociation 
is slow at both ends of the filament (T. D. Pollard et al., 1981).   
 Rates of actin subunit association are dependent on the bound nucleotide.  
Adenosine triphosphate (ATP) bound subunits are more stable than adenosine 
diphosphate (ADP) bound subunits in the actin filament nucleus (T. D. Pollard, 2016).  
The critical concentration for polymerization of ATP bound actin at the barbed end is 
0.1 mM compared to 1.8 mM for polymerization of ADP bound actin (Blanchoin et al., 
2002). Once an actin subunit has assembled into the filament the hydrolysis rate of 
bound Mg-ATP is much faster than the one of G-actin, at 0.3 sec-1 and 7 X 10-6 sec-1, 
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respectively (Blanchoin & Pollard, 2002).  Hydrolysis of ATP to ADP occurs soon after 
subunit addition, resulting in ATP bound subunits at the filament ends and tightly bound 
ADP, or ADP-Pi, bound subunits in the center (Carlier et al., 1986).  The process of 
ATP hydrolysis and phosphate release along the filament results in actin “treadmilling” 
– the steady-state addition of subunits at the barbed end and the simultaneous 
disassociation of subunits at the pointed end (Wegner, 1976). The rates of these 
processes seem to indicate that actin filaments should be inherently stable, however, in 
vivo experiments demonstrate the role of ABPs in providing an additional level of 
regulation.  In some cases, ABPs can lead to an unexpected high degree of filament 
instability (T. D. Pollard, 2016).  
 
Figure 1-2. Actin polymerization. Cartoon showing ATP- (T) and ADP- (D) actin 
association rates at the pointed (top) and barbed (bottom) ends.  (Modified from 
Pollard and Earnshaw 2007.)  
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Actin filament structure 
Actin filaments are left-handed helices comprised of 13 molecules per six turns 
and can be envisioned as two intertwined strands of actin monomers (Figure 1-3).  The 
axial repeat of the helix is 35.9 nm and the rise per subunit is 27.5 Å.  However, F-actin 
cannot be described as a structure with a single set of helical parameters since it has 
Figure 1-3:  Structure of the actin filament.  (left) Reconstruction of the actin 
filament from cryo-electron micrographs. (right) Cartoon of the actin filament 
showing the position of the pointed and barbed ends. (Figure from Fujii et al. 2010 
and adapted from Pollard 2016.) 
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been shown to exhibit both twist (Egelman et al., 1982) and subunit tilt variations 
(Galkin et al., 2002).  The two strands of F-actin are stabilized by interactions at the 
intra- and inter-strand level.  Intra-strand binding is predominantly due to the 
enveloping of a β-sheet of subdomain SD3 by the DNase I binding loop (D-loop) of the 
neighboring actin subunit, forming a “lock-and-key” interface (von der Ecken et al., 
2015).  Several salt bridges between SD3 and SD4 residues and numerous hydrophobic 
interactions between residues of adjacent subunits further reinforce intra-strand stability 
(von der Ecken et al., 2015).  The “hydrophobic plug” connecting three subunits of F-
actin contributes to the inter-strand stability of F-actin.  Although this connection was 
originally attributed to hydrophobic interactions, recent structural studies have 
demonstrated that these inter-strand contacts are the result of electrostatic bonds 
between the negatively charged surface of the plug with a patch of positive charge on 
the surface of the opposing actin (von der Ecken et al., 2015).	   
 
Myosin Motors 
Myosins belong to a large family of molecular motor proteins that bind actin 
filaments and generate mechanical force as a result of structural changes induced by the 
hydrolysis of ATP.  There are at least 35 classes, or types, of myosin motors categorized 
by sequence homology.  All myosins move toward the plus-end of actin, with the 
exception of myosin VI, which moves to the minus end (Wells et al., 1999). 
Independently of the type, all myosins consist of three primary functional domains 
(Figure 1-4).  The head domain, which is highly conserved across all myosins, contains 
both an actin-binding and a nucleotide-binding site. The neck domain, also known as 
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the lever arm, is a short alpha-helical strand containing from one to seven IQ motifs. 
Calmodulin-like light-chain subunits bind to the IQ motifs and increase the force-
transducing properties of the myosin by stiffening the neck. Extending from the neck, 
the tail domain consists primarily of a long alpha-helical strand.  The length of this 
region and the C-terminal sequence varies considerably across myosin types and is 
consistent with their function in the cell.  Most myosin types, including type II and type 
V, exist as homodimers due to a coiled-coil structure formed by complementary α-
helical tail domains. Phosphorylation of bound light-chains regulates the ability of type 
II myosin dimers to form filament ensembles, as well as the motor activity (Matsumura 
et al., 1998; Matsumura et al., 2001).  
The ability of myosin motors to exert force on actin filaments is directly coupled 
to their ATPase activity.  Myosins hydrolyze ATP in the absence of actin, however 
ADP and inorganic phosphate (Pi) release is very slow under these conditions.  Initial 
Figure 1-4: Cartoon of myosin dimer.  The globular heads are located at the N-
terminus and are linked to the coiled-coil tail by the neck domains which are 
stiffened by regulatory (RLC) and the essential (ELC) light chains.  (Modified, 
with permission, from Tajsharghi,  	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binding to actin causes myosin to release Pi, strengthening the attachment to actin 
(strong-bound state) and triggering the force generating power stroke of the molecule. 
Subsequently, ADP is released and ATP is free to bind to myosin, causing it to detach 
from the actin filament.  Unbound myosin hydrolyzes ATP, returning the head to the 
“cocked” position, readying it to start a new cycle (Figure 1-5).  
The kinetic cycles of all myosins contain the steps described above, however the 
rates of completion of each step are highly variable (De La Cruz et al., 2004). The 
variations in kinetic cycles generate myosin motors specialized for particular functions 
within the cell.  The ratio of the time spent in the strong-bound state versus the total 
cycle time is termed the duty ratio. Low duty ratio myosins are efficient at the 
cooperative translocation of actin.  This is clearly exemplified by the type II myosins 
moving actin filaments within the highly ordered sarcomere.  In contrast, cargo-
Figure 1-5. Myosin ATP hydrolysis cycle. Diagram showing the steps of ATP 
hydrolysis for myosin with weak actin-bound states in blue and strong actin-bound 
states in green.  (Used with permission from De La Cruz and Ostap, 2004).  
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transporting type V myosins are kinetically tuned to spend a large percentage of time in 
the strong-bound state. Myosins having a duty ratio of 0.5 and above are classified as 
processive – a characteristic that enables single myosin molecules to travel long 
distances on actin without detaching.	   
 
Myosin structure 
 High-resolution structural analysis of skeletal muscle myosin has revealed much 
about the relationship between myosin ATPase activity and its association with actin.  
The myosin head domain is divided into four principal subdomains:  the upper and 
lower 50-kDa, the N-terminal, and the converter subdomains (Figure 1.6).  The 
nucleotide-binding pocket resides between the upper 50-kDa and the N-terminal 
Figure 1-6:  Myosin head subdomains. The four principal head subdomains of 
type V myosin:  upper 50-kDa in blue (U50), lower 50-kDa in white (L50), N-
terminal in grey, and the converter in green  
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subdomains, while the actin binding region consists of four actin binding loops on, and 
between, the upper and lower 50-kDa subdomains.  A large opening between the upper 
and lower 50-kDa subdomains, known as the 50-kDa cleft, runs between the actin 
binding region and the nucleotide binding site (Rayment et al., 1993).  It is predicted 
that the 50-kDa cleft closes upon release of ADP, promoting the strong actin-bound 
state (Rayment et al., 1993; Volkmann et al., 2000).  The converter subdomain links the 
N-terminal subdomain and the lower 50-kDa subdomain with the light chain-reinforced 
lever arm, allowing for the translation of small structural changes in the head into large 
movements of the lever arm (Sweeney et al., 2010).  Allosteric effects between myosin 
dimer heads, or gating, are critical for the translocation of an actin filament and for the 
efficient movement of a motor along a fixed actin filament. 
 
Type V myosin 
 Type V myosins are obligate dimers found in diverse eukaryotic organisms 
where their central role is cargo transport (Reck-Peterson et al., 2000).  Canonical type 
V myosins, including the archetype MyoV, have two heavy chains consisting of a motor 
domain followed by a long α-helical neck region containing six IQ motifs.  The binding 
of calmodulin or calmodulin-like light chains to the IQ motifs stiffens the neck.  
Dimerization is facilitated by the formation of the coiled-coil tail domain that extends 
out from the neck and terminates at the globular cargo-binding domain (CBD).  The 
CBD associates with diverse cargo – e.g. vesicles, melanosomes, and mRNA – via 
adaptor protein complexes (Wu et al., 2002).  Typically type V myosins are processive 
with a step size of 36 nm, corresponding to the distance between the actin filament 
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helical repeat (Taylor, 2007). The 36 nm step size is likely the result of the combined 
~20-25 nm movement of the myosin V center of mass following rotation of the actin 
bound head and neck region, with the ~11-16 nm movement achieved by the diffusional 
search of the free head for the next actin binding site (Burgess et al., 2002; Moore et al., 
2001; Purcell et al., 2002; Sellers & Veigel, 2006; Veigel et al., 2002; Walker et al., 
2000). The tight distribution of step-size, and 13 actin monomer distance between the 
heads when both heads are bound to actin, indicates that myosin V is restricted to 
specific binding sites on the actin filament (Sellers & Veigel, 2006).  
 Type V myosins tend to have a high affinity for actin and spend a large portion 
of their kinetic cycle in the strong bound-state with actin.  Human MyoVa has an 
estimated duty ratio of 70%, constituting a highly processive motor (De La Cruz et al., 
1999). This characteristic is essential to MyoV’s ability to be an efficient cargo 
transporter and is a product of its kinetic cycle.  ADP release is the rate-limiting step of 
the actin-activated ATPase cycle for most type V myosin. In contrast, the release of Pi 
is relatively fast compared to conventional type II myosins in which Pi release is the 
rate-limiting step. The binding of nucleotide-free type V myosin to actin is more rapid 
than other myosin types, potentially due to a partially closed 50-kDa cleft even prior to 
actin binding (Coureux et al., 2003). Additionally, type V myosin has a strong affinity 
for F-actin when bound to ATP and ADP-Pi – conventionally the weak-bound states.  
The disassociation constant of ATP-bound MyoV for actin at physiological salt 
concentration is approximately 100 fold higher than myosin-II under comparable 
conditions (Berger et al., 1991; Yengo et al., 2002).  
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 Unexpectedly, in vitro kinetic studies have identified numerous non-processive 
type V myosins, including Myosin Vc (human) (Takagi et al., 2008), Myosin V (fruit 
fly) (Toth et al., 2005), Myo2p (budding yeast) (Hodges et al., 2009; Reck-Peterson et 
al., 2001), and Myo52 (fission yeast) (Clayton et al., 2010). However, in vivo studies 
have demonstrated that some non-processive type V myosins are required for cargo 
transport (Clayton et al., 2010; Hodges et al., 2009; Reck-Peterson et al., 2001).  
Regulation of non-processive type V myosins by ABPs, including tropomyosin, may 




 Tropomyosins are a family of alpha helical proteins that associate with actin 
filaments. The characteristic coiled-coil structure of tropomyosin results from the 
formation of parallel dimers that self-polymerize into filaments via head-to-tail 
interactions (Tobacman, 2008). The tropomyosin sequence exhibits the characteristic 
heptad-repeat – with amino acids labeled a-g – that leads to a coiled-coil structure.  
Residues a and d of the two α-helices interact to form the hydrophobic core of the 
tropomyosin molecule.  Stabilization of the structure is mediated by the formation of 
inter-strand salt bridges between amino acids e and g (Hitchcock-DeGregori, 2008) 
(Figure 1-7).  
 Filamentous tropomyosin lies along the F-actin groove (von der Ecken et al., 
2015) (Figure 1-8).  Unlike most actin binding proteins, tropomyosin binds F-actin with 
low affinity (Kd~10-3) (Wegner, 1979).  Structural studies have determined that 
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tropomyosin ‘hovers’ above F-actin at a distance of ~40 Å (von der Ecken et al., 2015).  
There are at least two models to explain the interactions between tropomyosin and actin.  
The first model describes tropomyosin binding to actin via localized regions present on 
the tropomyosin molecule that define the structural conformation of the copolymer 
(Singh et al., 2006). Alternatively, the “Gestalt-binding” model postulates that the 
binding affinity of the two polymers cannot be explained by the formation of a number 
of weak ionic interactions, but instead is the product of the two filaments’ 
complementary helical structures (Holmes et al., 2008).  At the core of the “Gestalt- 
binding” model is the observation that only tropomyosin in filamentous form has been 
observed decorating actin, and that tropomyosin filaments are able to readily shift 
positions relative to the actin filament.  
 
Figure 1-7. Conserved amino acid heptad repeat that forms tropomyosin 
coiled-coil structure.  The hydrophobic interactions between residues a and d are 
stabilized by ionic interactions between residues g and e. (Hitchcock-DeGregori, 
Tropomyos in.    
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Tropomyosin expression and localization 
 Mammalian cells contain four tropomyosin genes, TPM1-4.  Over 40 known 
tropomyosin isoforms are expressed from TPM1-4 through alternative splicing of 15 
exons (Gooding et al., 2008) (Figure 1-9). Tropomyosin isoforms are divided into two 
categories by their size.  High molecular weight isoforms contain approximately 284 
amino acids and span seven actin subunits. Low molecular weight isoforms contain 
approximately 248 amino acids and span six actin subunits.  The origin of the size 
Figure 1-8:  Full cryo-EM reconstruction of F-actin and decorated with 
tropomyosin. a. Actin (grey) with five central subunits in green and one subunit in 
cyan decorated with tropomyosin (yellow). b, Close-up view of a with the atomic 
and molecular model of an F-actin subunit (cyan) and tropomyosin (yellow) and 
their corresponding densities, respectively. The density corresponding to ADP is 




difference between tropomyosin isoforms resides in the N-terminal exons.  High 
molecular weight isoforms contain exon 1a together with either 2a or 2b while low 
molecular weight isoforms contain only exon 1b. Metazoan cells can express up to eight 
different tropomyosin isoforms – with comparable actin affinities – at a given time.   
 
Figure 1-9: Mammalian tropomyosin isoforms. Four mammalian 
tropomyosin genes (TPM1-4) produce up to 40 alternative splice isoforms.  
High molecular weight isoforms contain exon 1a together with either 2a or 
2b while low molecular weight isoforms contain only exon 1b.  
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 Extensive work has been done using tropomyosin isoform-specific antibodies to 
characterize the tropomyosin expression profile and subcellular localization within 
numerous mammalian cell types (Schevzov & O'Neill, 2008; Schevzov et al., 2011).  
Antibody labeling of neurons revealed Tpm3.1 and Tpm3.2 are present only in the 
neurite. Following treatment with the actin polymerization-blocking drug, cytochalasin 
B, the localization of Tpm3.1 and Tpm3.2 was diffuse in the growth cones. Removal of 
cytochalasin B returned Tpm3.1 and Tpm3.2 localization to the neurite (Schevzov et al., 
1997).  These studies demonstrate that the distinct intracellular localization of 
tropomyosin isoforms does not rely on transport mechanisms.  However, it does require 
the maintained integrity of actin structures at those locations.  At least seven 
tropomyosin isoforms are expressed in osteoclasts.  Tpm1.8 and Tpm4.2 are enriched at 
sites of osteoclast attachment and podosomes while Tpm3.1 is diffuse throughout the 
cell cytoplasm (McMichael et al., 2006). Tpm3.2 expressed in fibroblasts localizes to 
short actin filaments associated with the Golgi complex during the G1 phase of the cell 
cycle, while the highly similar Tpm3.1 predominantly localizes to stress fibers (Percival 
et al., 2004). A study conducted using mouse myoblasts evaluated the role of the 
tropomyosin N-terminus in regulating tropomyosin isoform localization.  Levels of the 
high molecular weight tropomyosin isoform, Tpm1.7, are low at the cell periphery of 
myoblasts compared to levels of the low molecular weight isoform, Tpm3.1. Replacing 
the N-termini of Tpm3.1 with the N-termini of Tpm1.7 did not result in diminished 
levels of the Tpm3.1 chimera, indicating that the N-terminus is not sufficient to direct 
tropomyosin isoform localization (Martin et al., 2010).	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 Recent evidence has implicated the formin family of unbranched-actin 
nucleating proteins as playing a role in the localization of tropomyosin isoforms.  
Decoration of specific actin structures with acetylated versus unacetylated tropomyosin 
is determined by formin activity in fission yeast (Johnson et al., 2014).  Mammalian 
cells, which express forty tropomyosin isoforms, have at least 15 different types of 
formins (T. D. Pollard, 2016). Dorsal stress fiber formation in human osteosarcoma 
cells requires at least five tropomyosin isoforms as well as the activity of specific 
formins (Hotulainen et al., 2006; Tojkander et al., 2011).  One model proposed to 
describe the role of formins in the localization of tropomyosin isoforms depicts formin 
attached to both the barbed end of a nucleated actin filament, as well as to the N-
terminus of tropomyosin (Gunning, Hardeman, et al., 2015).  The large number of 
formins expressed in mammalian cells could provide a mechanism for localizing 
tropomyosin isoforms to specific actin structures (Gunning, Hardeman, et al., 2015; 
Johnson et al., 2014), however further studies are needed to determine the extent of 
formins involvement in this process.  
 
Functional role of tropomyosin 
 
 The role of tropomyosin has been studied extensively in contractile muscle 
systems, in which, in concert with troponin and in response to varying levels of Ca2+, 
tropomyosin governs the ability of the myosin thick filament to form cross bridges with 
actin (Gordon et al., 2000).  This regulation is dependent on troponin in a Ca2+ level 
dependent manner.  At low Ca2+ levels, troponin is bound to actin and tropomyosin, 
maintaining tropomyosin in the “blocked” state. The binding of Ca2+ to troponin permits 
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an ~25° azimuthal shift of tropomyosin along actin to assume the “closed” state, 
allowing for initial myosin binding followed by a rapid shift by tropomyosin to the 
“open” state (Xu et al., 1999).  However, in the context of non-muscle cells, in which 
regulation by troponin and Ca2+ levels is absent, the role of tropomyosin in regulating 
myosin is less clear. 
 Previous studies have characterized the effects of overexpressing specific 
tropomyosin isoforms in non-muscle cells. These studies have added to our 
understanding of how tropomyosins function to regulate actomyosin structures and actin 
associated processes in a non-muscle setting.  Overexpression of Tpm3.1 in the rat 
cortical neuroblastoma B35 cell line led to increased levels of non-muscle type II 
myosins at specific actin structures:  myosin IIA at stress fibers and myosin IIB at the 
cell peripheral cortex (Bryce et al., 2003). Consequently, recruitment of myosin IIA to 
stress fibers inhibited lamellipodia formation and cell migration.  In contrast, Tpm1.12 
overexpression favored lamellipodia formation, reducing stress fiber formation, and 
resulting in an increase in cell motility (Bryce et al., 2003).  Additionally, Tpm3.1 
overexpression in B35 cells reduces the velocity and directional persistence of cell 
motility by decreasing the turnover rate of focal adhesions. B35 cells overexpressing 
Tpm1.7, which also localizes to stress fibers, did not affect directional persistence and 
resulted in a less marked decrease in velocity (Bach et al., 2009).   
 Decoration of actin filaments by specific tropomyosin isoforms blocks particular 
myosins from binding to actin.  Actin filaments containing Tpm1.6 exclude Myo1b in 
NRK cells (Tang et al., 2001) and inhibit Myo1c in vitro activity (McIntosh et al., 
2015).  In fission yeast, type I myosin is blocked from interacting with filaments that 
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contain tropomyosin.  Consequently, type I myosin localizes at actin structures 
containing the actin bundling protein fimbrin, which displaces tropomyosin from actin 
filaments (Clayton et al., 2010).  The actin binding protein complex, ADF/cofilin, is 
also regulated by the expression of different tropomyosin isoforms.  The actin severing 
activity of ADF/cofilin in B35 neuroblastoma cells is inhibited by overexpression of 
Tpm3.1, while overexpressing Tpm1.12 favors severing by cofilin (Bryce et al., 2003; 
Creed et al., 2011). The interplay between cofilin and tropomyosin could be the result 
of a competition for the same actin binding site (Kuhn et al., 2008).  Alternatively, 
changes to the actin filament structure induced by bound tropomyosin could inhibit 
cofilin binding, or the roles could be reversed (Kuhn & Bamburg, 2008).  
 Tropomyosin has also been shown to regulate actin polymerization and filament 
stability.  Over expression of Tpm3.1 in primary hippocampal neurons increases actin 
polymer levels (Schevzov, Fath, et al., 2008).  In vitro studies demonstrated that 
alpha/alpha- and alpha/beta-tropomyosin decrease the bulk actin polymerization rate by 
stabilizing actin filaments, thus reducing the number of actin filament ends (Hitchcock-
DeGregori et al., 1988).  Furthermore, decoration of purified F-actin with non-muscle 
tropomyosin decreased the rate of actin depolymerization at the pointed end by 44% 
(Broschat et al., 1989).   
 
Role of tropomyosin during development 
 Expression of tropomyosin isoforms is tightly regulated temporally and 
spatially.  Changes to tropomyosin expression during development can lead to aberrant 
neuronal outgrowth, organ defects, and death. Tropomyosin isoforms are important for 
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the control of actin filaments required for neuronal morphogenesis and neurite 
outgrowth in B35 neuroblastoma cells (Curthoys et al., 2014). Similarly, Tpm3.1 
expression promotes growth cones and increases the number of axonal branches and the 
number of dendrites while Tpm1.7 inhibits neurite outgrowth (Schevzov et al., 2005). 
The Drosophila tropomyosin II gene (TmII) regulates the size of the dendritic branch 
network and interacts with flamingo, a membrane receptor that regulates dendritic 
growth (Li et al., 2003). In addition to its roles in neurons, tropomyosin is an important 
regulator of cardiac development.  Translational regulation of alpha-tropomyosin 
isoforms is required for cardiac muscle morphogenesis (Rethinasamy et al., 1998). 
 
Involvement of tropomyosin in cancer 
 The loss of actin microfilament structures in transformed cancer cells was first 
described in 1975 (Pollack et al., 1975; Wang et al., 1976).  After this discovery, 
alterations in the tropomyosin profile of a variety of transformed cell lines have been 
characterized – indicating the potential involvement of tropomyosins in the 
transformation process (H. L. Cooper et al., 1985; Hendricks et al., 1981, 1984; Leavitt 
et al., 1986; Leonardi et al., 1982). A few striking trends have emerged from these 
studies.  Tpm3.1 expression is maintained in all characterized tumor cells (Stehn et al., 
2006).  The loss of Tpm2.1 correlates closely with cell transformation, while restoring 
Tpm2.1 levels – or increasing Tpm1.6 levels – reverses key transformation features 
(Bharadwaj et al., 2005; Boyd et al., 1995; Gunning, Hardeman, et al., 2015). 
Additionally, the overall amount of tropomyosin decreases in transformed cells 
compared to untransformed cells (Leonardi et al., 1982). Tpm1.8 expression levels 
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directly correlate with B16 mouse melanoma cell motility (Helfman et al., 2008; 
Miyado et al., 1996).  While some tropomyosin-dependent effects appear to be 
consistent across studies, the effect of a given tropomyosin can vary considerably 
between two cell types. For instance, Tpm2.1 inhibits cell adhesion-independent growth 
in Syrian hamster embryo cells (Boyd et al., 1995).  However, Tpm2.1 promotes 
sensitivity of breast cancer cells to anoikis by increasing stress fiber formation 
(Bharadwaj et al., 2005).  
 Several studies have indicated potential mechanisms to explain the role of 
tropomyosin in the transformation process, some of which rely on the activity of 
myosins.  Depletion of Tpm3.1 and Tpm3.2 reduces actomyosin-induced tension at the 
apical junctions of the zonula adherens in epithelial colorectal adenocarcinoma cells 
(Caldwell et al., 2014).  Furthermore, measurements conducted with an atomic force 
microscope demonstrate the role of tropomyosin isoforms in regulating cell stiffness in 
a myosin II dependent manner.  Over expression of Tpm3.1 in B35 neuroblastoma cells 
led to the greatest increase in cell stiffness (Jalilian et al., 2015).  Tropomyosins are also 
involved in signaling pathways that contribute to cell growth and proliferation.  The 
ERK-regulated cell proliferation pathway depends on Tpm3.1 for the nuclear 
translocation of pERK by importin7 (Schevzov et al., 2015). Understanding the 
mechanism of the involvement of tropomyosin in the transformation process is critical 







Fission yeast as a model organism for studying the actin cytoskeleton 
 
Fission yeast provides a powerful system for studying actomyosin regulation 
due to its highly tractable genome as well as its relatively simple actin cytoskeleton and 
few myosin types.  The sole fission yeast actin gene produces the subunits for the three 
primary actin structures:  actin patches, actin cables, and the contractile ring (Figure 1-
10).  Actin patches are a dynamic network of branched actin and type I myosin involved 
in endocytosis and membrane remodeling.  Actin cables are unbranched parallel 
bundles of actin that act as polarized tracks for cargo transport by type V myosin 
motors. The contractile ring consists of unbranched anti-parallel actin bundles that 
guide cell wall deposition during cytokinesis through the “ratcheting” action of type II 
myosin (Lord et al., 2005).  
Fission yeast contains only five myosin motor isoforms, including two type II 
myosins: the essential Myo2 required for ring constriction, and the non-essential Myp2 
(Mulvihill et al., 2003; Sladewski et al., 2009).  Additionally, there are two type V 
myosins: Myo51 and Myo52. Myo52 is required for cargo transport along cables while 
Myo51 appears to aid in cytokinesis (East & Mulvihill, 2011; Win et al., 2001). The 
single headed Myo1, active at actin patches, is the only type I myosin in fission yeast 
(Lee et al., 2000). The sole fission yeast tropomyosin, Cdc8, contains 161 amino acids 
and covers four actin subunits.  Cdc8 exists in two forms, acetylated and unacetylated.  
Approximately 80% of Cdc8 is N-terminally acetylated and is required to regulate 
Myo2 at the ring during mitosis (Coulton et al., 2010). However, acetylation of Cdc8 is 






Scope and Purpose 
 
The focus of the studies included in this dissertation is characterizing the role of 
tropomyosin in regulating non-muscle myosin, with the intent of improving our 
understanding of tropomyosin function in normal and diseased non-muscle cells. 
Previously we identified the fission yeast tropomyosin Cdc8 as playing a role in 
regulating the activity of type V myosins.  Decoration of F-actin with Cdc8 increases 
the actin affinity of purified full length Myo52, producing a 2 to 3-fold decrease in Km. 
Similarly, the Vmax of Myo52 actin-dependent ATPase activity increased ~50% with the 
addition of Cdc8. Using an in vitro actin filament gliding assay, we demonstrated that, 
similar to the fission yeast type II myosin (Stark et al., 2010), Myo52-driven, Cdc8-
decorated actin filament velocities were significantly reduced compared to those of bare 
actin (Clayton et al., 2010).  An increase in the percentage of total cycle time spent in 
the strong-bound state could explain the observed decrease in filament gliding rates.  To 
address this possibility, the average length of motile actin filaments observed at low 
Figure 1-10: Primary actin structures in fission yeast depicted during the cell cycle. 
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myosin concentrations was measured to calculate the duty ratios.  Using this method, 
shorter filament lengths indicate a decrease in the required number of engaged myosin 
motors due to increased occupancy of the strong-bound state.  It was calculated that 
Myo52 had a two-fold increase in duty ratio in the presence of Cdc8.  To characterize 
the role of Cdc8 in Myo52-dependent transport in vivo, a fully functional integrated 
myo52-3xGFP was tracked in wild type and Cdc8 deficient cells.  Wild type cells 
exhibited faster Myo52 particles and more frequent motile events (Clayton et al., 2010).  
It was previously shown that the budding yeast type V myosin, Myo2p, requires 
tropomyosin for processive movement (Hodges et al., 2012).  In chapter 2, a 
combination of single molecule in vitro studies and fission yeast based in vivo studies 
are described that address the molecular mechanism and physiological relevance of 
Myo52 regulation by Cdc8. Single molecules of Myo52 are shown to require Cdc8 
decorated actin tracks for processive movement.  Furthermore, ensembles of Myo52 
that mimic multiple motors bound to physiological cargo also require Cdc8. These 
results demonstrate a mechanism that provides the ability to sort Myo52-driven cargo 
transport to specific actin tracks based on the presence or absence of tropomyosin.   
Unlike the single tropomyosin isoform found in fission yeast, mammals depend 
on a much larger number of tropomyosin isoforms, with at least 40 isoforms expressed 
in humans (Gunning, Hardeman, et al., 2015).  Tropomyosin expression is tightly 
regulated during mammalian development (Schevzov & O'Neill, 2008), although the 
reason why mammalian cells depend on so many tropomyosin isoforms is not clear.   A 
likely explanation is that higher eukaryotic cells may rely on diverse tropomyosin 
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isoforms to regulate more complex actin cytoskeletal structures and a large number of 
expressed myosin motor types.   
The importance of regulating non-muscle tropomyosins has been suggested over 
the years by studies that have characterized the tropomyosin profile of multiple 
transformed cancer cell types (Helfman et al., 2008; Stehn et al., 2006).  Transformed 
neuroblastoma and melanoma cells exhibit a characteristic shift from expressing 
predominantly high molecular weight tropomyosin isoforms to expressing the two low 
molecular weight isoforms Tpm3.1 and Tpm4.2 (Stehn et al., 2013).  A novel type of 
anti-cancer therapeutic targeting Tpm3.1 has shown promise as an effective treatment in 
neuroblastoma and melanoma mouse models, although the mechanism through which 
these compounds work has not been determined (Stehn et al., 2013).   
In chapter 3, a combination of in vitro and in vivo studies are employed to 
characterize the ability of Tpm3.1 and Tpm4.2 to regulate type V and type II myosins in 
a myosin isoform dependent manner. Both Tpm3.1 and Tpm4.2 enhance Myo52 
ATPase and actin filament gliding motility in a manner similar to Cdc8.  In contrast, the 
highly processive type V myosin, MyoVa, is not affected by these tropomyosins in 
filament gliding assays, although their activity is slightly reduced in ATPase assays.  
The type II non-muscle myosin Myo2 activity was enhanced with Tpm3.1 and Tpm4.2, 
however these tropomyosins starkly inhibited both the ATPase activity and gliding 
filament motility of type II skeletal muscle myosin SKMMII. 
In chapter 4, the results described in chapters 2 and 3 are discussed within the 
broader context of actomyosin regulation by non-muscle tropomyosins, as well as how 
these studies improve our understanding of this process in normal and diseased cells.  
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As an appendix, chapter 5 describes a preliminary study that examines the regulation of 
Myo2 by a panel of tropomyosins, revealing a tropomyosin isoform dependent level of 
actomyosin regulation.  This study supports a mechanism of actomyosin regulation by 
tropomyosin that is determined in part by the terminal tropomyosin sequences involved 
in head to tail polymerization.  
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CHAPTER 2:  FISSION YEAST TROPOMYOSIN SPECIFIES DIRECTED 





Joseph E. Clayton, Luther W. Pollard, Maria Sckolnick, Carol S. Bookwalter, Alex R. 




Department of Molecular Physiology and Biophysics, University of Vermont, 
Burlington, VT 05405 
 
*Present address: Department of Chemistry and Physical Sciences, Quinnipiac 




GFP, green fluorescent protein; Qdot, quantum dot; ScMyo2p, class V myosin 
Saccharomyces cerevisiae; SpMyo2p, class II myosin from Schizosaccharomyces 





A hallmark of class-V myosins is their processivity—the ability to take multiple steps 
along actin filaments without dissociating. Our previous work suggested, however, that 
the fission yeast myosin-V (Myo52p) is a nonprocessive motor whose activity is 
enhanced by tropomyosin (Cdc8p). Here we investigate the molecular mechanism and 
physiological relevance of tropomyosin-mediated regulation of Myo52p transport, using 
a combination of in vitro and in vivo approaches. Single molecules of Myo52p, 
visualized by total internal reflection fluorescence microscopy, moved processively 
only when Cdc8p was present on actin filaments. Small ensembles of Myo52p bound to 
a quantum dot, mimicking the number of motors bound to physiological cargo, also 
required Cdc8p for continuous motion. Although a truncated form of Myo52p that 
lacked a cargo-binding domain failed to support function in vivo, it still underwent 
actin-dependent movement to polarized growth sites. This result suggests that truncated 
Myo52p lacking cargo, or single molecules of wild-type Myo52p with small cargoes, 
can undergo processive movement along actin-Cdc8p cables in vivo. Our findings 
outline a mechanism by which tropomyosin facilitates sorting of transport to specific 




The myosin motors are large, actin-activated ATPases that use the free energy 
generated from Pi release to power conformational changes leading to contractility, 
tension, or transport. Tropomyosins, on the other hand, are small, dimeric, α-helical 
coiled-coil proteins that bind end to end along both sides of the actin filament (Gunning 
et al., 2005). Tropomyosin promotes actin filament stability and has long been known to 
work in concert with the troponin complex to regulate striated muscle myosin-II motors 
by gating access to the actin track in a calcium-dependent manner (J. A. Cooper, 2002; 
Gunning et al., 2005). Whereas troponin is unique to muscle, tropomyosin is 
widespread, yet exactly how this protein influences myosins in nonmuscle systems is 
not clear. There is a vexing number of possibilities with respect to actomyosin 
regulation when one considers the abundance of tropomyosin and myosin isoforms in 
mammalian cells. Humans use four tropomyosin genes to generate >40 tropomyosin 
isoforms by alternative splicing, and there are at least 10 classes of myosin motors in 
humans, each with multiple isoforms. 
Fission yeast provides an excellent model system with which to probe the role of 
tropomyosin in nonmuscle myosin regulation. Cdc8p is the sole tropomyosin, which is 
essential for the formation of the actomyosin contractile ring and the actin cables 
spanning the length of the cell (Balasubramanian et al., 1992). Moreover, only three 
classes of myosins (I, II, and V) are represented in fission yeast. We recently showed 
that Cdc8p promotes myosin-II activity and actomyosin ring assembly during 
cytokinesis (Stark et al., 2010). This same regulation may account for the ability of 
tropomyosins to enhance the activity of smooth muscle myosin-II and platelet myosin-II 
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(myosin-IIA) observed in past studies (Merkel et al., 1989; Nosaka et al., 1984; M. 
Yamaguchi et al., 1984). Cdc8p also regulates unconventional myosins from fission 
yeast (Clayton et al., 2010).  Decoration of actin filaments with Cdc8p inhibited 
myosin-I (Myo1p) but enhanced the activity of the myosin-Vs (Myo51p and Myo52p). 
The ability of Cdc8p to inhibit Myo1p is consistent with studies showing that 
tropomyosin can block myosin-I activity in higher eukaryotes (Collins et al., 1990; 
Fanning et al., 1994; Tang & Ostap, 2001). However, the ability of Cdc8p to promote 
Myo51p and Myo52p activity was the first example of tropomyosin-mediated 
regulation of a class V myosin. 
Most myosin-V isoforms studied to date are high–duty ratio motors, meaning 
that they spend a large proportion of their ATPase cycle in the strong actin-bound ADP 
or apo states. The high duty ratio and dimeric nature of such motors facilitates 
processive, hand-over-hand walking along actin filaments (De La Cruz et al., 1999; 
Mehta et al., 1999). Recent kinetic and motility studies suggest, however, that a 
subpopulation of myosin-V isoforms are low–duty ratio motors. These include class V 
myosin from the budding yeast Saccharomyces cerevisiae Sc Myo2p; (Reck-Peterson et 
al., 2001), Drosophila myosin-V (Toth et al., 2005), human myosin-Vc (Takagi et al., 
2008; Watanabe et al., 2008), and fission yeast Myo52p (Clayton et al., 2010). Using 
single-molecule techniques, we recently confirmed that Sc Myo2p is not processive on 
bare actin but, surprisingly, becomes highly processive when it walks on actin-
tropomyosin. Tropomyosin increases the time the motor spends strongly attached to 
actin by slowing the rate of Mg2+-ADP release. This is the first example of 
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tropomyosin switching a motor from nonprocessive to processive motion (Hodges et al., 
2012). 
Here we used single-molecule approaches and total internal reflection 
fluorescence (TIRF) microscopy to show that decoration of actin by Cdc8p also 
converts single molecules of fission yeast Myo52p into processive motors. In vitro 
results suggest a mechanism involving both kinetic and cooperative regulation of 
actomyosin interactions by tropomyosin-actin. Our findings have physiological 
relevance because truncated Myo52p, lacking its cargo-binding domain (and thus 
presumably operating as a single molecule), can still undergo directed motility along 
actin cables in the cell. Of importance, small ensembles of Myo52p motors that support 
directed transport in vivo also relied on tropomyosin to support motility when 
reconstituted in vitro. We propose that tropomyosins can sort myosin molecules to 




Fission yeast tropomyosin converts Myo52p into a processive motor 
We tested whether Myo52p was processive or not using single-molecule assays. Our 
previous duty ratio estimates (percentage of time a motor spends in the strong actin-
bound ADP/apo state per ATPase hydrolysis cycle), calculated from actin-activated 
ATPase and ensemble motility data, suggested that Myo52p comes up well short of 
being processive even in the presence of tropomyosin (Clayton et al., 2010). A 
minimum duty ratio of 50% is required for processive stepping of a myosin-V dimer 
33	  	  
along an actin filament. To examine this question further, we coexpressed a truncated 
heavy meromyosin (HMM) form of Myo52p, which lacks the C-terminal cargo-binding 
globular tail domain, with the Myo52p light chains Cam1p (calmodulin) and Cdc4p 
(essential light chain) in the baculovirus-Sf9 insect cell system (Figure 2-1A). The 
Myo52p-HMM had a C-terminal biotin tag for attachment to streptavidin–quantum dots 
(Qdots) or a streptavidin-conjugated fluorophore (Figure 2-1A) and a FLAG tag to 
facilitate affinity purification (Figure 2-1, A and B). 
TIRF microscopy was used to determine whether single Myo52p motors were 
able to walk processively along actin filaments. Fluorescently labeled actin filaments 
were attached to a glass coverslip, and a solution containing Myo52p labeled with 
fluorescent quantum dots was added. No processive movements were observed 
(Supplemental Movie 2-S1), suggesting that Myo52p has a duty ratio <50% on bare 
actin under our in vitro conditions. On the basis of the observation that budding yeast 
myosin-V (Sc Myo2p) requires tropomyosin for processivity, and because the actin 
cables on which Myo52p transports cargo in the cell depend on Cdc8p for their 
assembly and maintenance (Arai et al., 1998; Balasubramanian et al., 1992), we 
repeated these experiments using Cdc8p-decorated filaments. Recombinant Cdc8p was 
purified from bacteria (Figure 2-1C). Strikingly, the presence of Cdc8p facilitated 
processive movements of Myo52p– quantum dots (Qdots) along actin filaments (Figure 
2-2, A and B, and Supplemental Movie 2-S1). The switch in behavior was quite 
dramatic, given that the processive runs showed efficiency in terms of both speed 
(∼1.25 µm/s; Figure 2-2C) and run length (∼0.6 µm; Figure 2-2D), values comparable to 
those for bona fide processive myosin-Vs previously characterized using this approach 
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(Warshaw et al., 2005). The experiments were repeated using Myo52p labeled with a 
streptavidin-Cy3 fluorescent dye instead of quantum dots. The Cy3-labeled Myo52p 
molecules moved processively only when actin filaments were decorated with Cdc8p 
(Supplemental Figure 2-S1 and Supplemental Movie 2-S2). We assume that both of our 
labeling approaches achieve single-molecule resolution, thereby demonstrating that 
tropomyosin is required for Myo52p to move processively. 
 
Tropomyosin increases Myo52p run frequency and run length at low ATP concentration 
The ability of tropomyosins to activate Myo52p processivity suggests that tropomyosin 
may increase the duty ratio of the motor by increasing the occupancy of the strong 
actin-bound ADP or apo states. To further understand the mechanism by which Cdc8p 
contributes to Myo52p processivity, we repeated our single-molecule studies at low (10 
µm) ATP. At this concentration ATP binding becomes the rate-limiting step of the 
Myo52p ATPase cycle, allowing the strongly bound apo state to predominate. Thus the 
nonphysiological low ATP concentration increases the duty ratio, and Myo52p remains 
strongly bound to actin as it awaits an ATP molecule to bind and dissociate the head 
from actin. Under these low-ATP conditions, Myo52p exhibited processive movements 
along both bare and Cdc8p-decorated actin filaments (Supplemental Movie 2-S3). Thus 
Cdc8p becomes dispensable for processivity when the Myo52p duty ratio is artificially 
increased, similar to what was observed with Sc Myo2p from budding yeast and its 
cognate tropomyosin, Tpm1p (Hodges et al., 2012). Although the speeds of these 
Myo52p movements were not statistically different on actin versus actin-Cdc8p tracks 
(Figure 2-3A), as expected they were more than 10-fold lower than those observed on 
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actin-Cdc8p filaments at 2 mM ATP (Figure 2-2C). Surprisingly, the frequency at 
which these runs were observed was more than sevenfold higher when actin was 
decorated with Cdc8p (Figure 2-3B and Supplemental Movie 2-S3). Furthermore, the 
average run lengths were approximately twofold longer in the presence of Cdc8p 
(Figure 2-3C). The increased run frequency and run length with Cdc8p at low ATP 
highlights that Cdc8p does something beyond enhancing the duty cycle of the motor. 
 
Myo52p motors work in small clusters that rely on tropomyosin for effective transport 
Myo52p moves along actin cables to polarized growth sites (Grallert et al., 2007), and 
the localization of a number of different proteins has been shown to rely on this 
transport, namely α-glucan synthase Mok1p (Win et al., 2001), synaptobrevin Syb1p 
(Edamatsu et al., 2003), β-1,3-glucan synthase Bgs1p (Mulvihill et al., 2006), chitin 
synthase Chs2p (Martin-Garcia et al., 2006), CLIP-170 homologue Tip1p  (Martin-
Garcia et al., 2009), exocytosis factor Mug33p (Snaith et al., 2011), and GTPase Ypt3p 
(Lo Presti et al., 2011). Whereas Myo52p may well operate as a single molecule to 
directly transport some of these proteins to the cortex, it probably also works as an 
ensemble in which multiple motors work together to mediate motility via attachment to 
a larger cargo, such as the previously characterized Syb1p- or Mug33p-associated 
vesicles (Edamatsu & Toyoshima, 2003; Snaith et al., 2011). We used clathrin light 
chain (Clc1p-3x green fluorescent protein [GFP]) at endocytic patches as a standard to 
estimate the numbers of Myo52p-3xGFP molecules in particles undergoing directed 
transport. Clc1p is ideal since its distribution at patches has already been quantified 
(Sirotkin et al., 2010), and its signal intensity is very similar to Myo52p, enabling 
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accurate extrapolation between the similar-sized Clc1p patches and Myo52p particles. 
We performed time-lapse analysis of a mixed population of myo52-3xGFP and clc1-
3xGFP cells (Figure 2-4A). Analysis of the two strains in the same field allowed us to 
estimate the number of Myo52p molecules per motile particle, which ranged from 4 to 
34, with a mean of 12.9 ± 6.7 (Figure 2-4, B and C). Thus four molecules of Myo52p 
appear to be enough to support directed transport of cargoes in vivo. However, although 
an average of 13 molecules may be associated with a given cargo, the number of 
Myo52p molecules contacting the track at any one time is probably less, given the 
geometry and size of cargoes such as vesicles. Even if Myo52p-decorated vesicles or 
organelles became stretched out along the length of the actin cable as they moved along 
the track, approximately half of the Myo52p molecules would still be out of reach of the 
track, meaning that an average of six to seven molecules is enough to propagate 
transport in vivo. 
The in vitro motility behavior of physiologically relevant numbers of Myo52p 
molecules was examined in the presence or absence of Cdc8p. Qdots were mixed with a 
10-fold molar excess of Myo52p-HMM, yielding approximately three to five molecules 
per Qdot based on geometrical considerations. As seen at the single-molecule level, 
bare actin was unable to support transport by multiple Myo52p motors (Supplemental 
Movie 2-S4). However, Cdc8p-decorated actin filaments supported continuous motility 
by multiple motors (Supplemental Figure 2-S2A and Supplemental Movie 2-S4). These 
overloaded Qdots exhibited similar speeds to single Myo52p molecules, and their 
average run length was ∼1.3-fold higher (Supplemental Figure 2-S2B). This modest 
increase upon overloading the quantum dots suggests that single Myo52p motors are 
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responsible for motility at the limiting molar ratio. Our findings indicate that Cdc8p is 
essential for Myo52p transport powered by physiological ensembles of motors. 
 
Myo52p molecules lacking a cargo-binding domain undergo continuous motility along 
actin cables in vivo 
To test the importance of cargo binding in Myo52p transport and polarization, we 
constructed a truncated form of Myo52p in which the C-terminal cargo-binding 
globular tail domain was replaced with a triple GFP tag (Myo52pΔCBD-3xGFP). The 
truncated form did not support cellular function, as reflected by morphological defects 
reminiscent of a myo52Δ strain (Figure 2-5A) and the inability to colocalize with the 
cargo-associated protein Ypt3p (Supplemental Figure 2-S3). However, despite the loss-
of-function phenotype, Myo52pΔCBD could still accumulate at polarized growth sites 
(Figure 2-5B). 
Time-lapse analysis of live cells revealed that polarization of Myo52pΔCBD 
stemmed from its ability to undergo directed transport, similar to full-length Myo52p 
(Figure 2-6A and Supplemental Movie 2-S5). Analysis of these intracellular movements 
revealed a slightly slower speed for the truncated form (Figure 2-6B), whereas the 
average run length and frequency of the Myo52pΔCBD particle movements were 
indistinguishable from those of full-length Myo52p (Figure 2-6, C and D). Although our 
findings with the truncated form imply that individual Myo52p molecules are capable of 
intracellular motility when not bound to a cargo, quantitative analysis of 
Myo52pΔCBD-3xGFP fluorescence intensities estimated an average of 10 truncated 
Myo52p molecules/motile particle (Figure 2-6E). Although motile single molecules 
38	  	  
cannot be resolved amid the background fluorescence of cytoplasmic Myo52pΔCBD-
3xGFP, our cellular counts suggest that truncated motors often move together in groups 
(making them amenable to detection in our setup). 
When actin cables were depolymerized by latrunculin A, Myo52pΔCBD-3xGFP 
showed diffuse fluorescence throughout the cytoplasm, unlike full-length Myo52p-
3xGFP, which showed punctuate fluorescence, which presumably reflects clustering on 
cargoes (Figure 2-5B). These data suggest that the groups of truncated motors detected 
by time-lapse microscopy (Figure 2-6B) are actin dependent and unlikely due to 
aggregation propagated by either the motor itself or the 3xGFP of the fusion construct. 
We further verified this by repeating the latrunculin A experiment using an alternative 
fluorescent protein tag to label Myo52pΔCBD. We wanted to rule out the possibility 
that the 3xGFP tags specifically favor aggregation and multiple motor-based transport 
of Myo52pΔCBD when molecules are put into closer contact (i.e., when they bind close 
by one another along the actin track). We instead used the equally bright tdTomato tag. 
Like Myo52pΔCBD-3xGFP, Myo52pΔCBD-tdTomato transported to polarized growth 
sites in an actin-dependent manner, becoming diffuse throughout the cytoplasm upon 
treatment with latrunculin A (Supplemental Figure 2-S4). We conclude that actin-
tropomyosin cables support processive movements of Myo52pΔCBD molecules. The 
observation that these movements can be visualized as relatively uniform groups of 
Myo52p molecules moving in unison may reflect cooperative binding of motors to 





Here we show that adding tropomyosin to the actin filament converts a single molecule 
of fission yeast myosin-V from a nonprocessive to a processive motor. Tropomyosin 
also activates continuous transport by multiple motors of Myo52p bound to a Qdot. 
Small ensembles of motors more closely mimic the situation found on cellular cargoes. 
We determined an average of 13 motors per motile particle in vivo, although this 
number likely exceeds the number of track-engaged motors at any time. In vivo, 
Myo52p shows continuous motion along tropomyosin-bound actin cables. Processive 
motion would ensure highly efficient movement of larger cargoes by multiple Myo52p 
motors, as well as facilitating transport of cytoplasmic proteins or smaller cargoes by 
single motors. Whether or not an actin track has tropomyosin bound to it provides a 
simple mechanism by which myosin motor function can be sorted to specific cellular 
actin structures (Figure 2-7). Cdc8p-mediated sorting of Myo52p motors to cables 
ensures directed transport toward polarized growth sites, as well as contri-buting to the 
extension and organization of the cables (Lo Presti et al., 2012), all of which help to 
establish normal cell shape. This tropomyosin-dependent regulation may be relevant in 
higher eukaryotes, given that nonprocessive myosin-Vs have also been identified in 
Drosophila and humans (Takagi et al., 2008; Toth et al., 2005; Watanabe et al., 2008). 
 
Tropomyosin promotes Myo52p processivity by altering the kinetics of the motor 
Regulation of Myo52p processivity by Cdc8p ultimately involves significant changes in 
the kinetic properties of the motor. The duty cycle of a processive motor must be >50% 
to ensure that one head remains strongly bound to actin at any time. The duty cycle can 
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be increased by increasing the time in the strongly bound states or decreasing the time 
in the weakly bound states. Our previous work with class II myosin from the fission 
yeast Schizosaccharomyces pombe (Sp Myo2p) and Myo52p showed that Cdc8p 
increases the VMAX and apparent actin affinity of these motors in actin-activated 
ATPase assays while slowing the rates at which they propel actin filaments in filament 
gliding assays (Clayton et al., 2010; Stark et al., 2010). Given the increased actin 
affinities and the fact that filament gliding is rate limited by the strong actin-bound state 
(Siemankowski et al., 1985), the ability of tropomyosin to activate processivity lies in 
its ability to favor the strong actin-bound state of the actomyosin ATPase cycle, 
resulting in an increased duty ratio for the motor. The observation that Cdc8p increases 
Myo52p VMAX values in ATPases (Clayton et al., 2010) suggests that activation of 
Myo52p processivity may largely involve a significant increase in the rate of Pi release, 
facilitating rapid movement into the strong actin-bound ADP state. The detailed effects 
of tropomyosin depend on the specific myosin isoform. Both Myo52p and budding 
yeast Myo2p are class V myosins, but they are affected differently by tropomyosin. For 
Myo2p, steady-state, actin-activated ATPase assays showed no change in either KM or 
VMAX value when actin was decorated with tropomyosin (Hodges et al., 2012). For 
this myosin, duty cycle was increased by slowing the rate of ADP release and the rate of 
ATP-induced dissociation of the acto-motor complex (Hodges et al., 2012). The effects 





Alternative modes of Cdc8p regulation and their relationship to established models 
Myo52p was capable of processive movements on bare actin at low ATP. This 
condition increases motor duty ratio because ATP binding becomes rate limiting, so that 
myosin motors spend most of their time without nucleotide in the strong actin-bound 
rigor state. The ability of bare actin to support processivity is consistent with a general 
mechanism in which tropomyosin mediates processivity by increasing the duty ratio, as 
opposed to changing the structure of the actin track. Strikingly, the frequency at which 
Myo52p processivity was observed at low ATP was sevenfold higher when actin was 
decorated with Cdc8p. The decreased KM value (higher affinity) seen in the presence of 
tropomyosin in ATPase assays (Clayton et al., 2010) may account for this increase in 
run frequency. In addition, as with Sc Myo2p and budding yeast Tpm1p, the average 
Myo52p run length increased at low ATP in the presence of Cdc8p. This was 
unexpected, given that the predicted duty ratio would be >95% whether tropomyosin is 
present or not. One possibility to explain the enhanced run length is improved gating 
between the two heads, perhaps by slowing ADP release from the lead head, as 
previously suggested for Sc Myo2p (Hodges et al., 2012). Meanwhile, recent structural 
evidence suggests a more direct role for tropomyosin in myosin recruitment. A 
pseudoatomic model of a rigor motor head actin-tropomyosin complex, based on an 8-Å 
structure determined by cryo–electron microscopy, showed for the first time a direct 
interaction between myosin and tropomyosin in the actin-bound complex (Behrmann et 
al., 2012). Collectively these findings suggest that tropomyosin promotes processivity 
by doing more than simply increasing the duty cycle of the motor. A related 
mechanism, which can also apply to multiple motors, may lie in cooperative binding of 
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myosin heads. Such a mechanism is a variation on the role of tropomyosin in striated 
muscle contraction, where the troponin-tropomyosin complex establishes a “blocked” 
state on the actin filament that prevents myosin-II binding (Gordon et al., 2000; Lehrer, 
1994; Swartz et al., 1996). Binding of Ca2+ to troponin triggers a shift in the position of 
tropomyosin from the “blocked” to “closed” state. The ”closed” state is initially 
inhibitory, as it requires binding of a myosin head to complete the shift in tropomyosin 
position to the “open” state, which then allows unrestricted and cooperative binding of 
neighboring myosin heads. The high concentrations of actin and myosin in muscle, 
coupled with the precise manner in which these molecules are lined up in sarcomeres, 
favors rapid movement into the “open” state. Cryo–electron microscopy showed that 
Cdc8p-decorated actin filaments assume the “closed” state (Skoumpla et al., 2007), 
which predictably results in inhibition of skeletal muscle myosin-II actin-activated 
ATPase activity (East, Sousa, et al., 2011). However, these same Cdc8p-actin filaments 
significantly enhance Sp Myo2p and Myo52p activity in the same assays (Clayton et al., 
2010; Stark et al., 2010). Enhancement of Myo52p activity by Cdc8p does not appear to 
be limited by the “closed” state, given that very low concentrations of Myo52p (<1 nM) 
were able to walk on Cdc8p-decorated filaments in single-molecule assays. Moreover, 
the actin-dependent clustering of truncated Myo52p motors lacking cargo that we 
observed on actin cables in vivo is reminiscent of cooperative binding, in which binding 
of one head favors the binding of neighboring heads close by. We propose that the 
“closed” state is multifaceted and can activate (e.g., Myo52p with Cdc8p), inhibit (e.g., 
skeletal muscle myosin-II with Cdc8p), or block (e.g., fission yeast myosin-I with 
Cdc8p) motor activity, depending on the tropomyosin and myosin isoforms in play. In 
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the case of Myo52p and Cdc8p, the “closed” state may favor activation by promoting 
initial actomyosin interactions that subsequently influence the position of Cdc8p and 
favor more interactions. However, this same state can completely block or limit initial 
interactions with muscle myosin needed for any subsequent cooperative binding. 
Activation of Myo52p by Cdc8p may reflect kinetic regulation in combination with 
cooperative effects by which the strong binding of one head shifts the position of 
tropomyosin, thus favoring strong binding of additional heads nearby. 
 
Materials and Methods 
Fission yeast strains and genetic approaches 
Standard fission yeast genetic and cell biology protocols were used (Moreno et al., 
1991). myo52Δ::natR (h−, MLY 759), myo52-3xGFP:kanR (h−, MLY 975), 
myo52ΔCBD-3xGFP:kanR (h+, LP 86), and clc1-3xGFP: kanR uch2-mCherry:natR 
(h+, LP 123) haploid strains were constructed by performing genomic integrations using 
the relevant G418-resistant (kanR) or nourthreothricin-resistant (natR) antibiotic 
markers and (YE5S-drug) rich media selection plates (Bahler et al., 1998; Snaith et al., 
2010). The myo52ΔCBD-3xGFP strain encodes a C-terminal truncation in which the 
globular cargo-binding region of the Myo52p tail (amino acids 1025–1516) is replaced 
by a triple-GFP tag. The SFY 527/528 strain background (h−/h+ leu1-32 ura4-D18 
his3-D1 ade6-M216/ade6-M210) was used throughout. An exception was the 
myo52ΔCBD-tdTomato strain, which was a gift from Sophie Martin (University of 




A PCR product encoding a truncated form of Myo52p (amino acids 1–1056 spanning 
the motor domain, light chain–binding region, and coiled-coil region) was amplified 
from S. pombe cDNA. The fragment was cloned into the baculovirus transfer vector 
pAcSG2 with a C-terminal biotin tag, followed by a C-terminal FLAG tag for 
purification by affinity chromatography. The biotin tag is an 88–amino acid sequence 
segment from the Escherichia coli biotin carboxyl carrier protein, which, when 
expressed in Sf9 cells, is biotinylated at a single Lys residue. The tag is used for 
attachment to streptavidin-coated Qdots or streptavidin-Cy3. Myo52p light-chain genes 
(cam1 and cdc4) were amplified from S. pombe cDNA and cloned into the dual 
expression vector pAcUW51 behind separate promoters. The fidelity of constructs was 
confirmed by DNA sequencing. A Cdc8p construct was used to overexpress an 
acetylated-mimicking form of the protein in E. coli. The cdc8 gene was PCR amplified 
from S. pombe cDNA using the following primers: 5′, NdeI-cdc8, 
CAATCATATGGCTAGCATGGATAAGCTTAGAGAG (the NdeI site is italicized, 
and the start codon of the cdc8 ORF is underlined); and 3′, BamHI-cdc8 
CAATGGATCCCTACAAGTCCTCA-AGAGCTT (the BamHI site is italicized, and 
the cdc8 stop codon is underlined). The 5′ primer encodes an Ala-Ser (acetylation 
mimicking) dipeptide immediately upstream of the cdc8 start codon. The start codon for 
the recombinant protein actually lies in the second half of the NdeI site, allowing for 
incorporation of the Ala-Ser codons. The resultant oligonucleotide was cloned into the 
pET3 vector and fidelity confirmed by DNA sequencing. The cam1 and cdc4 Myo52p 
light-chain open reading frames were cut out from the pAcUW51 baculovirus vector 
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using BamHI and inserted into the BamHI sites of pET3a for bacterial expression. The 
orientation and fidelity of the light-chain sequences was confirmed by restriction 
analysis and DNA sequencing. The pREP41-tdTomato-ypt3 plasmid was a gift from 
Sophie Martin (Lo Presti & Martin, 2011) and was used to visualize Myo52p-dependent 
localization of Ypt3p at polarized growth sites (Supplemental Figure 2-S3). 
 
Live-cell imaging 
Tracking of Myo52p-3xGFP particle motility used a Nikon (Melville, NY) Eclipse Ti-U 
inverted microscope equipped with a 100× PlanApo objective lens (1.40 numerical 
aperture [NA]) for through-the-objective near-TIRF microscopy. The GFP was excited 
with a 473-nm laser line. The angle at which the laser entered the objective was tuned 
such that the illumination was not perfect TIRF, allowing the laser to excite the entire 
thickness of the cell, yet resulting in a better signal-to-noise ratio than with epi-
illumination. Images were obtained using a Stanford Photonics XR/Turbo-Z camera 
running Piper Control (Stanford, CA) version 2.3.39, software. The pixel resolution was 
145.5 nm. Data were collected at 7.7 frames/sat room temperature. Movement of GFP 
particles over time was tracked manually using ImageJ (National Institutes of Health, 
Bethesda, MD). A Nikon TE2000-E2 inverted microscope with motorized fluorescence 
filter turret and a Plan Apo 60× (1.45 NA) objective was used to capture differential 
interference contrast and epifluorescence images (using GFP or tetramethyl rhodamine 
isothiocyanate filters) at room temperature. Fluorescence used an EXFO X-CITE 120 
illuminator (Mississauga, Ontario, Canada). NIS Elements software (Melville, NY) was 
used to control the microscope, together with two Uniblitz shutters (Rochester, NY). A 
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Photometrics (Tucson, AZ) CoolSNAP HQ2 14-bit camera was used for single-plane 
colocalization imaging of Myo52p-3xGFP (or Myo52pΔCBD-3xGFP) and Tomato-
Ypt3p (Supplemental Figure 2-S2). Time-lapse movies of cells monitoring Clc1p-
3xGFP patches and Myo52p-3xGFP (or Myo52pΔCBD-3xGFP) particles were captured 
using an Andor (Belfast, UK) 16-bit electron-multiplying charge-coupled device 
camera. Images were captured every 2 s as z-stacks (every 0.70 µm over 4.2 µm) 
spanning the cell depth. Cell suspensions (3 µl) were mounted on flat, 30-µl media pads 
(solidified by 1% agarose) prepared on the slide surface. VALAP (1:1:1 Vasoline, 
lanolin, and paraffin) was used to seal slides and coverslips. Latrunculin A treatment 
(10 µM) was used to remove actin cables from myo52-3xGFP and myo52ΔCBD-
3xGFP cells growing exponentially in YE5S media. Images were captured 45 min after 
the addition of the drug (or dimethylsulfoxide in controls). 
 
Protein purification 
Baculovirus harboring the Myo52p and Cam1p-Cdc4p constructs was prepared using 
established protocols (Hodges et al., 2009). Sf9 cells were coinfected with both the 
heavy and light chains. Sf9 cells were grown in suspension and harvested at 72 h. 
Harvested cells were pelleted at low speed for 10 min and resuspended in lysis buffer 
(300 mM NaCl, 10 mM imidazole, pH 7.2, 1 mM ethylene glycol tetraacetic acid 
[EGTA], 5 mM MgCl2, 2 mM dithiothreitol [DTT], 5 µg/ml leupeptin, 0.8 mg/ml 
benzamidine, and 0.4 µg/ml recombinant Cam1p and Cdc4p). Cells were lysed by 
sonication and pelleted after addition of 2 mM Mg2+-ATP. The supernatant was 
incubated with anti-FLAG resin for 1.5 h, transferred to a column, and washed with 100 
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ml of FLAG buffer (300 mM NaCl, 10 mM imidazole, pH 7.2, 1 mM EGTA, 1 mM 
NaN3). The sample was eluted off the column by the addition of FLAG buffer 
containing 150 µg/ml FLAG peptide. Protein-rich fractions were pooled followed by 
three rounds of dialysis (3 × 1 l) against storage buffer (300 mM KCl, 10 mM 
imidazole, pH 7.2, 1 mM NaN3, 1 mM DTT), followed by addition of 5 µg/ml 
leupeptin. Cdc8p and Myo52p light-chain proteins were produced in E. coli BL21 DE3–
competent cells. Cultures were grown in LB media at 37°C and protein overexpression 
induced at an OD600 of 0.5 by addition of 0.4 mM isopropyl-β-D-thiogalactoside. Cells 
were harvested after overnight induction at 25°C. Proteins were purified as described 
previously (Pruyne et al., 1998).  Cell pellets were resuspended in lysis buffer (100 mM 
NaCl, 10 mM imidazole, pH 7.2, 2 mM EDTA, and 1 mM DTT) and sonicated. Lysates 
were boiled for 10 min while stirring, then pelleted to remove denatured protein and 
other debris. Soluble tropomyosin (or light chains) were precipitated from the 
supernatant by lowering the pH to 0.2 U below the isoelectric point of the relevant 
protein. The protein precipitate was resuspended in 50 mM NaCl, 1 mM DTT, and 10 
mM imidazole, pH 7.4, and dialyzed for three rounds (3 × 1 l) against the same buffer, 
followed by addition of 5 µg/ml leupeptin. 
Actin was purified from acetone powder (Spudich et al., 1971), and myosin-II 
was purified as described previously (Margossian et al., 1982). 
 
Visualizing Myo52p-Qdot and Myo52p-Cy3 motility by TIRF microscopy 
Myo52p-HMM (0.2 µM) was mixed with a twofold molar excess of actin and 2 mM 
Mg2+-ATP and centrifuged for 20 min at 400,000 × g to remove any myosin that was 
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unable to dissociate from actin in the presence of ATP. To investigate processivity of 
individual myosin V motors, Myo52p was then mixed with a 10-fold molar excess of 
655-nm streptavidin-coated Qdots (Invitrogen, Grand Island, NY). In principle, a small 
fraction of Qdots will have two or more motors bound, but previous controls 
demonstrated that Qdots are driven primarily by a single motor at this mixing ratio 
(Hodges et al., 2012). To investigate multiple motor transport, we mixed Qdots with a 
10-fold excess of Myo52p to generate Qdots with multiple motors, with typical 
saturation yielding ∼3–5 motors/Qdot based on geometrical considerations (Hodges et 
al., 2009; Hodges et al., 2012). Flow cells made from glass coverslips were prepared by 
introducing the following solutions into the flow cell: 0.1 mg/ml N-ethylmaleimide–
modified skeletal muscle myosin (5-min incubation), 5× rinse of 1 mg/ml bovine serum 
albumin (BSA; 2 min), 2 µM rhodamine-phalloidin–labeled chicken skeletal muscle 
actin filaments (plus or minus 1 µM tropomyosin; 2–5 min), 5× rinse with motility 
buffer, and, finally 0.2 nM Myo52p in motility buffer with 2 mM MgATP. Motility 
buffer consists of 50 mM KCl, 25 mM imidazole, pH 7.4, 4 mM MgCl2, 1 mM EGTA, 
50 mM DTT, 1 mg/ml BSA, 3.5 µM fission yeast calmodulin (Cam1p), 3.5 µM fission 
yeast essential light chain (Cdc4p), and an oxygen-scavenging system (3 mg/ml 
glucose, 0.1 mg/ml glucose oxidase, and 0.18 mg/ml catalase). For experiments with 
Cdc8p, 1 µM Cdc8p was included in the motility buffer to prevent dissociation from 
actin. For single-molecule experiments using Cy3-labeled Myo52p, motors were mixed 
with a fivefold molar excess of Cy3-streptavidin (Invitrogen) and diluted to a final 
concentration of 0.5 nM in buffer C-50 (10 mM imidazole, pH 7.4, 50 mM KCl, 4 mM 
MgCl2, 1 mM EGTA, 10 mM DTT, plus light chains, oxygen scavengers, and 2 µM 
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Cdc8p when included) before adding to the flow cell. Alexa 635-phalloidin–labeled 
chicken skeletal muscle actin filaments were used. Through-the-objective TIRF 
microscopy was performed at room temperature using the Nikon Eclipse Ti-U 
microscope equipped with a 100× Plan Apo objective lens (1.49 NA) and auxiliary 1.5× 
magnification. Fluorophores were excited with a 473-nm (Qdots) or 532-nm (Cy3 and 
actin) laser line, and images were obtained using the XR/Turbo-Z camera running Piper 
Control software, version 2.3.39. The pixel resolution was 95.0 nm, and data were 
collected at 5–30 frames/s. Qdot movement along rhodamine-labeled actin filaments 
was tracked by hand using ImageJ. For each event, we required Qdot-labeled Myo52p 
to move continuously for at least three frames to qualify as a run. Cy3 movement along 
Alexa 635–labeled actin filaments was tracked using the MtrackJ plug-in for ImageJ. 
Runs that artificially terminated by running off the end of an actin filament were not 
included in the run length analysis. 
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Figure 2-1: Myo52p constructs and purification. (A) Top, linear representations of 
full-length and truncated Myo52p constructs. The positions of specific domains are 
indicated on the full-length construct. Truncated Myo52p-HMM (amino acids 1–1056 
of the Myo52p heavy chain) was used in TIRF-based motility assays. This construct 
contains a biotin tag following the coiled-coil for attachment to streptavidin-coated 
Qdots or streptavidin-Cy3, and a FLAG tag to facilitate affinity purification. The C-
terminus of both full-length and truncated forms of Myo52p were fused to triple GFP 
for in vivo studies (Figures 4–6). Bottom, corresponding illustrations of double-headed 
Myo52p molecules. Six light chains (black ovals) bind to the IQ region of each Myo52p 
polypeptide. (B, C) Purified protein samples after SDS–PAGE and gel staining with 
Coomassie blue. Molecular weight standards are included in the left lanes. (B) Myo52p-
HMM after elution from anti-FLAG purification resin. HMM was co-overexpressed 
with its two (untagged) light chains: Cam1p and Cdc4p. These light chains were also 
purified independently (see Materials and Methods) and added to HMM samples at 10-
fold molar excess to minimize light-chain dissociation and suboptimal Myo52p motor 
activity in biochemical assays. (C) Fission yeast tropomyosin Cdc8p was purified from 






Figure 2-2: Fission yeast tropomyosin is required for transport of single Myo52p 
molecules along actin filaments. Processive movement of Myo52p-HMM molecules 
coupled to Qdots (1:10 M ratio) along rhodamine-phalloidin–labeled actin filaments 
using TIRF microscopy. (A) Movement of a Myo52p-Qdot (green) along a Cdc8p-
decorated actin filament (red). Bar, 4 µm. Other representative events are presented in 
Supplemental Movie S1. (B) Kymograph showing a typical Myo52p-Qdot run along an 
actin-Cdc8p filament. (C) Histogram of the speed distribution of Myo52p-Qdots. (D) 
Run length histogram of Myo52p-Qdots moving on Cdc8p-actin tracks. The red curve 






Figure 2-3: Movements of single Myo52p molecules along actin and actin-
tropomyosin tracks at low ATP concentration. Processive movement of Myo52p-
HMM molecules coupled to Qdots (1:10 M ratio) along rhodamine-phalloidin–labeled 
actin filaments at low ATP concentration (10 µM) using TIRF microscopy. 
Representative events are presented in Supplemental Movie S3. (A) Speeds of Myo52p-
Qdots on actin vs. actin-Cdc8p tracks (n = 17, actin alone; n = 104, actin-Cdc8p). (B) 
Relative frequency of Myo52p runs along actin vs. actin-Cdc8p tracks (17 runs/1123.8 
µm available actin vs. 104 runs/959.6 µm available actin-Cdc8p). The frequency of 
Myo52p movements on actin alone was normalized to 1.0. (C) Histogram of run lengths 
for Myo52p molecules along actin vs. Cdc8p-decorated actin tracks. The red curves 







Figure 2-4: Estimating the numbers of Myo52p molecules per motile particle in the 
cell. The signal intensity of GFP in motile Myo52p-3xGFP particles was used to 
estimate the number of Myo52p molecules/particle. Clathrin light-chain (Clc1p-3xGFP) 
signal was used as a standard based on its previously characterized distribution at actin 
patches (40 molecules/patch; Sirotkin et al., 2010). (A) Representative time-lapse 
images of a mixed population of myo52-3xGFP and clc1-3xGFP cells (after growth on 
YE5S rich medium at 25°C). clc1-3xGFP cells were distinguished from myo52-3xGFP 
cells by inclusion of a genomic uch2-Cherry fusion, which marks nuclei red. The GFP 
(green) images shown are maximum projections generated from seven z-stacks. The 
arrowheads track the movement of three different motile Myo52p particles. Bar, 4 µm. 
(B) Histogram comparing the average GFP intensities for motile Myo52p particles and 
Clc1p patches. (C) Histogram of the distribution of Myo52p GFP intensities expressed 







Figure 2-5: The cargo-binding domain of Myo52p is essential for in vivo function 
and clustering of Myo52p in subcellular particles in the absence of actin. (A) Wild-
type and myo52 mutant strains were grown at 32°C in YE5S rich media before 
microscopic imaging. Representative differential interference contrast (DIC) images of 
wild-type myo52+ (myo52-3xGFP) cells (left), myo52 null mutants (center), and the 
truncation mutant (myo52ΔCBD-3xGFP, right), which lacks sequence encoding the C-
terminal cargo-binding domain (amino acids 1025–1516). Both mutants show a 
characteristic loss-of-function phenotype reflected by defects in cell shape (Motegi et 
al., 2001; Win et al., 2001). (B) Wild-type (myo52-3xGFP) and mutant (myo52ΔCBD-
3xGFP) cells were grown at 25°C in YE5S rich media before imaging. Representative 
DIC and fluorescence micrographs show the subcellular localization of full-length 
Myo52p-3xGFP (top) and Myo52pΔCBD-3xGFP (bottom) upon treatment with 





Figure 2-6: Myo52p molecules lacking their cargo-binding domain undergo 
efficient motility along actin cables. (A) Time-lapse montages showing directed 
movement of full-length Myo52p-3xGFP (top) and truncated Myo52pΔCBD-3xGFP 
(bottom) particles in wild-type myo52-3xGFP and myo52ΔCBD-3xGFP cells, 
respectively (after growth on YE5S rich medium at 25°C). Directed movements were 
captured over time using TIRF microscopy. Far right, maximum projections of the 
particle trajectories. Bar, 4 µm. Representative events from the myo52ΔCBD-3xGFP 
strain are also presented in Supplemental Movie S5. (B) Histogram of the speed 
distribution of full-length Myo52p and Myo52pΔCBD particles. (C, D) Average run 
length (n = 45 in C) and event frequency (cell number = 82–122 in D) of motile 
Myo52p and Myo52pΔCBD particles. (E) Histogram of Myo52pΔCBD GFP intensity 






Figure 2-7: Sorting of Myo52p to actin cables during interphase. An interphase cell 
uses two distinct actin structures: 1) endocytic actin patches (blue) made up of branched 
actin filament networks that associate with myosin-I (Myo1p) and lack tropomyosin 
(Cdc8p), and 2) actin cables (green) made up of unbranched polarized Cdc8p-decorated 
actin filaments that support Myo52p transport throughout the cell cycle (Kovar et al., 
2011). Box, the presence of Cdc8p on actin cables facilitates Myo52p interactions by 
converting cytoplasmic Myo52p molecules into processive motors, which preferentially 
bind to and move efficiently along the cables. The absence of tropomyosin at actin 
patches fails to support Myo52p processivity, preventing inappropriate interactions 
between myosin-V and endocytic actin structures.  
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Figure 2-S1. Cy3-labeled Myo52p molecules move processively along actin-Cdc8p 
filaments. Single Myo52p-HMM molecules were coupled to Cy3 in order to track their 
ability to move along Alexa 635-phalloidin-labeled actin filaments using TIRF 
microscopy. A) Movement of a representative Myo52p-Cy3 molecule (green) along a 
Cdc8p-decorated actin filament (red). Bar: 2 mm.  Other representative events are 
presented in Supplementary Movie 2. B) Representative kymograph summarizing a 
typical Myo52p-Cy3 run along an actin-Cdc8p filament. C) Histogram summarizing the 
distribution of Myo52p-Cy3 speeds (n=100). D) Histogram of run lengths for Myo52p-
Cy3 along Cdc8p-decorated actin tracks (n=114). The red curve shows the exponential 






Figure 2-S2. Cdc8p activates the motility of fluorescence Qdots coated with 
multiple Myo52p motors. Qdots were saturated with Myo52p-HMM molecules 
(yielding ~3-5 motors/Qdot) to track the ability of multiple Myo52p molecules to 
support movement along rhodamine phalloidin-labeled actin filaments using TIRF 
microscopy. Only actin filaments decorated with tropomyosin (Cdc8p) supported 
movement of these Myo52p-coated Qdots. A) Movement of a representative Myo52p-
coated Qdot (green) along a Cdc8p-decorated actin filament (red). Bar: 4 µm. Other 
representative events are presented in Supplementary Movie 4. B) Histograms 
comparing run lengths of Qdots associated with single (n=103) versus multiple (n=117) 
Myo52p molecules along Cdc8p-decorated actin tracks. The red curves show 





Figure 2-S3. The cellular function of Myo52p relies on its C-terminal cargo-
binding domain. Wild-type myo52-3xGFP and mutant myo52DCBD-3xGFP cells 
were grown at 25o C in YE5S rich media prior to microscopic imaging. Representative 
DIC and epi-fluorescence images showing the localization of Myo52p-3xGFP or 
Myo52pDCBD-3xGFP (GFP) and a Myo52p cargo (GTPase Ypt3p, Tomato-Ypt3p) in 
wild-type and mutant cells. Unlike in wild-type cells, Ypt3p is not transported with 






Figure 2-S4. Polarized localization of truncated Myo52p lacking its cargo-binding 
domain relies on actin filaments. myo52DCBD-tdTomato cells were grown at 25o C 
in YE5S rich media prior to imaging. Representative DIC and fluorescence micrographs 
show the sub-cellular localization of Myo52pDCBD-tdTomato upon treatment with 
DMSO (control, left) or 10 mM Latrunculin A (right). Bar: 4 mm. 
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Supplementary Movie Legends 
 
Movie 2-S1. Cdc8p-decorated actin filaments support the processive movement of 
single Myo52p-Qdot molecules. Left: Failure of Myo52p-HMM-Qdots (green) to move 
processively on bare actin filaments (red) in the presence of 2 mM ATP. Right: In 
contrast, Myo52p-HMM-Qdots can move processively on Cdc8pdecorated actin 
filaments. Data were collected using TIRF microscopy with a capture rate of 30 
frames/s and are played back at this speed. Scale bar: 2 µm. 
 
Movie 2-S2. Cdc8p-decorated actin filaments support the processive movement of 
single Myo52p-Cy3 molecules. Cy3-labeled Myo52p-HMM (green) moving 
processively on actin-Cdc8 filaments (red) in the presence of 2 mM ATP. Data were 
collected using TIRF microscopy with a capture rate of 5 frames/s and are played back 
at this speed. Scale bar: 2 µm. 
 
Movie 2-S3. Processive movement of Myo52p molecules on bare actin and Cdc8p-
decorated actin filaments at low concentrations of ATP. Left: A Myo52p-HMM-Qdot 
(green) moving processively on bare actin filaments (red) in the presence of 10 µM 
ATP. Right: Myo52p-HMM-Qdots moving processively on Cdc8p-decorated actin 
filaments in 10 µM ATP. Data were collected using TIRF microscopy with a capture 
rate of 1 frame/s and are played back at 30 frames/s (sped-up 30x). Scale bar: 2 µm. 
 
Movie 2-S4. Cdc8p-decorated actin filaments support movement of Qdots by multiple 
Myo52p molecules. Left: Failure of Qdots (green) bound by multiple Myo52p-HMM 
motors to move along bare actin filaments (red) in the presence of 2 mM ATP. Right: In 
contrast, Qdots bound by multiple Myo52p- HMM motors can move processively on 
Cdc8p-decorated actin filaments. Data were collected using TIRF microscopy with a 
capture rate of 30 frames/s and are played back at this speed. Scale bar: 2 µm. 
 
Movie 2-S5. The directed motility of Myo52p molecules in the cell does not rely on the 
C-terminal cargobinding domain. In vivo directed motility of Myo52pΔCBD-3xGFP 
particles (green) made from clusters of molecules lacking their C-terminal cargo-
binding domains in the myo52ΔCBD-3xGFP strain. Data were collected using epi-
fluorescence microscopy with a capture rate of 10 frames/s; played back at 100 frames/s 
(sped up 10x). 
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Myosins and tropomyosins represent two cytoskeletal proteins that often work together 
with actin filaments in contractile and motile cellular processes. While the specialized 
role of tropomyosin in striated muscle myosin-II regulation is well characterized, its 
role in nonmuscle myosin regulation is poorly understood. We previously showed that 
fission yeast tropomyosin (Cdc8p) positively regulates myosin-II (Myo2p) and myosin-
V (Myo52p) motors. To understand the broader implications of this regulation we 
examined the role of two mammalian tropomyosins (Tpm3.1cy/Tm5NM1 and 
Tpm4.2cy/Tm4) recently implicated in cancer cell proliferation and metastasis. Like 
Cdc8p, the Tpm3.1cy and Tpm4.2cy isoforms significantly enhance Myo2p and 
Myo52p motor activity, converting nonprocessive Myo52p molecules into processive 
motors that can walk along actin tracks as single molecules. In contrast to the positive 
regulation of Myo2p and Myo52p, Cdc8p and the mammalian tropomyosins potently 
inhibited skeletal muscle myosin-II, while having negligible effects on the highly 
processive mammalian myosin-Va. In support of a conserved role for certain 
tropomyosins in regulating nonmuscle actomyosin structures, Tpm3.1cy supported 
normal contractile ring function in fission yeast. Our work reveals that actomyosin 
regulation by tropomyosin is dependent on the myosin isoform, highlighting a general 




Tropomyosins form strand-like molecules made up of parallel dimeric coiled-
coils (Hitchcock-DeGregori, 2008).  The association of tropomyosin with actin 
promotes filament stability and is known to regulate associations with actin-binding 
proteins such as myosin motors (Barua et al., 2013; Barua et al., 2014; Bryce et al., 
2003; Clayton et al., 2010; Coulton et al., 2010; Fanning et al., 1994; Lehrer, 1994; 
Stark et al., 2010; Tang & Ostap, 2001), filament cross-linkers (Clayton et al., 2010; 
Creed et al., 2008; Skau et al., 2010), filament severing factors (Bernstein et al., 1992; 
Fattoum et al., 1983; Ishikawa et al., 1989; Nakano et al., 2006; Ono et al., 2002) (Fan 
et al., 2008), filament cappers (Fowler et al., 1993; Weber et al., 1994)and actin 
nucleation factors (Blanchoin et al., 2001; Skau et al., 2009; Wawro et al., 2007). The 
mechanism by which tropomyosin regulates myosin has been well studied in muscle, 
yet we are only now beginning to learn how tropomyosin regulates myosin function in 
nonmuscle cells. There is still much to be learned in this area given the multiple classes 
of myosins and >40 tropomyosin isoforms expressed in mammalian cells (Gunning et 
al., 2005). 
Fission yeast has recently proved to be a useful model with which to study 
tropomyosin function owing to its tractable genetics, well-defined actin cytoskeleton, 
and established actin biochemistry (Kovar et al., 2011). Fission yeast tropomyosin 
(Cdc8p) is restricted to the unbranched formin-mediated actin filaments that make up 
the contractile rings used in cytokinesis and the actin cables used in intracellular 
transport and maintenance of cell shape (Balasubramanian et al., 1992; Johnson et al., 
2014; Kovar et al., 2011; Lo Presti et al., 2012). By contrast, Cdc8p is absent from the 
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Arp2/3-mediated branched actin utilized in endocytic patches (Balasubramanian et al., 
1992; Kovar et al., 2011). Each of the three fission yeast actin structures associate with 
different myosins (East & Mulvihill, 2011; Kovar et al., 2011), and previous work with 
Cdc8p highlighted a role for tropomyosin in the regulation of these actin-based motors. 
As opposed to limiting access to the actin track as in muscle (Lehrer, 1994), decoration 
of actin with Cdc8p positively regulates myosin-II (Myo2p) activity and function at 
contractile rings (Stark et al., 2010).  In addition, myosin-V (Myo52p) activity and 
transport along cables is favored by Cdc8p (Clayton et al., 2014; Clayton et al., 2010). 
In contrast to Myo2p and Myo52p, decoration of actin with Cdc8p inhibits myosin-I 
(Myo1p) in vitro (Clayton et al., 2010).  This negative regulation presumably helps to 
restrict Myo1p motor activity to the branched actin networks (that lack Cdc8p) at 
endocytic patches. 
Tropomyosins form filaments that associate weakly with actin, forming a co-
polymer in which tropomyosin wraps longitudinally along both sides of the actin 
filament (Gunning et al., 2005).  In such co-polymers each tropomyosin covers four to 
seven actin monomers depending on the tropomyosin isoform in play (Gunning et al., 
2005). Neighboring tropomyosins associate with one another via end-to-end interactions 
between their N- and C-termini (Hitchcock-DeGregori, 2008).  These interactions 
account for cooperative tropomyosin-actin associations and facilitate tropomyosin self-
assembly at low ionic strength (Tobacman, 2008).  Mutational analysis of the Cdc8p N-
terminus revealed a role for this region in promoting actin association and Cdc8p 
polymer formation (East & Mulvihill, 2011). 
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Interestingly, Cdc8p can be acetylated on its N-terminal methionine, a 
modification that alters actin-tropomyosisn structure, enhances actin associations, and 
contributes to Cdc8p function in the cell(Coulton et al., 2010; Skoumpla et al., 2007). 
Acetylated Cdc8p predominates at the contractile ring and is important for myosin-II 
localization and ring function, whereas unacetylated Cdc8p predominates at actin cables 
and faithfully supports Myo52p transport in the cell (Coulton et al., 2010). Thus, two 
specific forms of tropomyosin are generated from one isoform in fission yeast. The 
choice of fission yeast actin-nucleation factor (i.e. the formin isoform) distinguishes 
which of the two forms of Cdc8p are recruited to the two different unbranched actin 
filaments structures in the cell (Johnson et al., 2014). 
In contrast to fission yeast, a large variety of tropomyosins are expressed in 
mammalian cells, primarily generated through alternative splicing of a uniform set of 
exons from four different genes (TPM1-TPM4) (Geeves et al., 2015; Gunning et al., 
2005). Some isoforms are expressed in a tissue-specific manner and are classified as 
striated muscle-specific (from skeletal and cardiac muscle tissues), smooth muscle-
specific, or brain-specific. The remaining isoforms are referred to as “cytoplasmic,” 
being distributed amongst all other cell types. The different tropomyosins can also be 
broken down into two general classes based on sequence length. Low molecular weight 
(LMW) tropomyosins are ∼248 amino acids in length and incorporate exon 1b of the 
TPM gene (Fig. 3-1A); whereas high molecular weight (HMW) tropomyosins are ∼284 
amino acids long and utilize exons 1a and 2a (or 2b) (Fig. 3-1A). 
In this study we compared the influence of Cdc8p and two LMW cytoplasmic 
tropomyosins implicated in cancer cell growth and metastasis on four different myosins 
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(Myo2p, Myo52p, skeletal muscle myosin-II, and chick brain myosin-Va). A 
combination of in vitro and in vivo approaches suggest that the ability of tropomyosin 
to positively regulate nonmuscle myosins Myo2p and Myo52p is not restricted to 
Cdc8p. Moreover, the effects of tropomyosin on myosin activity differ depending on the 
myosin isoform involved underscoring a general concept in tropomyosin-mediated 
myosin regulation. Such regulation has the potential to provide tight specification of 
both nonmuscle and muscle actomyosin function in complex cellular environments. 
This work has broad implications with regard to sorting of actomyosin function in 
cancer cells and developing muscle tissue. 
 
Results 
Selecting Representative Mammalian Tropomyosin Isoforms 
We wished to compare the role of fission yeast Cdc8p with nonmuscle mammalian 
tropomyosins previously implicated in myosin function in cancer cells. We chose to 
focus on two LMW tropomyosin isoforms (Tpm3.1cy/Tm5NM1 and Tpm4.2cy/Tm4) 
originating from the TPM3 and TPM4 genes, respectively (Fig. 3-1A). We are 
employing the latest nomenclature to describe mammalian tropomyosin isoforms 
(Geeves et al., 2015). As such Tpm3.1cy/Tm5NM1 and Tpm4.2cy/Tm4 will be referred 
to as Tpm3.1cy and Tpm4.2cy, respectively from here on in. 
Our choice of tropomyosins reflects information gleaned from previous work. 
Tpm3.1cy and Tpm4.2cy were shown to regulate stress fiber formation and myosin-II 
recruitment to fibers in B35 neuroblastoma and U2OS osteosarcoma cells respectively 
(Bryce et al., 2003; Tojkander et al., 2011). Furthermore, Tpm3.1cy, its closely related 
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isoform Tpm3.2cy, and Tpm4.2cy represent the predominant LMW isoforms found in 
primary tumors and tumor cell lines (Stehn et al., 2006). Interestingly, Tpm3.1cy and 
Tpm3.2cy were recently shown to be essential for neuroblastoma cell proliferation, and 
represent the only two tropomyosin isoforms up-regulated upon transformation of both 
primary immortalized human BJ fibroblasts and human melanoma cells (Stehn et al., 
2013). Previous studies revealed that overexpression of Tpm3.1cy generates actin stress 
fibers exhibiting reduced susceptibility to traditional actin-targeting drugs, suggesting 
that tropomyosin composition can influence drug action (Creed et al., 2008). 
Importantly, recently developed anti-cancer compounds targeting Tpm3.1cy and 
Tpm3.2cy are showing promise based on their ability to inhibit tumor cell motility and 
growth (Stehn et al., 2013). 
N-terminal acetylation of tropomyosin has been shown to be important for both 
Cdc8p (Coulton et al., 2010; Skoumpla et al., 2007) and striated muscle α-
tropomyosin/Tpm1.1st (Heald et al., 1988; Hitchcock-DeGregori et al., 1987; 
Urbancikova et al., 1994) function. While post-translational modification offers another 
potential interesting avenue of regulation, we largely focused on the function of 
acetylated-mimicking forms of Cdc8p, Tpm3.1cy, and Tpm4.2cy purified following 
overexpression in Escherichia coli (Fig. 3-1B). Chicken skeletal muscle actin represents 
the standard actin isoform employed in all our in vitro studies. 
 
Differential Regulation of Myo2p and Skeletal Muscle Myosin-II by Mammalian 
Tropomyosins 
We compared the ability of Cdc8p, Tpm3.1cy, and Tpm4.2cy to regulate full-length 
fission yeast myosin-II (Myo2p) and full-length skeletal muscle myosin-II (SKMM-II) 
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using bulk actin-activated ATPase and ensemble actin filament gliding assays. The 
activities of Myo2p and SKMM-II were compared in an identical fashion in both 
assays. The concentration of myosin used in the ATPase assays was generally much 
lower (0.03–0.09 µM) than the various concentrations of actin/actin-tropomyosin 
filaments present (0.1–30 µM). In contrast, the concentration of myosin (5 nM) 
employed in the filament gliding assays was closer to the actin/actin-tropomyosin 
filament concentration used (25 nM). 
Michaelis-Menten analysis was employed to compare the ATPase activity of 
Myo2p and SKMM-II with actin or actin-tropomyosin filaments. Cdc8p increased the 
maximal ATPase rate (VMAX) and the overall catalytic efficiency of Myo2p 
approximately twofold (Fig. 3-2A; Table 3-1). Tpm3.1cy and Tpm4.2cy also enhanced 
Myo2p ATPase activity with a similar potency (Fig. 3-2A; Table 3-1). In stark contrast 
to the positive effect of tropomyosins on Myo2p, Cdc8p, and both cytoplasmic 
tropomyosins inhibited the ATPase activity of SKMM-II (Fig. 3-2B; Table 3-1). This 
inhibition does not appear to depend on the acetylation status of the tropomyosins since 
absence of the acetylation-mimicking Ala-Ser dipeptide (on the N-termini of Cdc8p or 
Tpm3.1cy) did not significantly influence the ability of the tropomyosins to inhibit 
SKMM-II activity (Fig. 3-3A). 
Decoration of actin filaments with Cdc8p led to a significant drop in the rate of 
Myo2p-driven actin filament gliding, an effect that was also observed with Tpm3.1cy 
and Tpm4.2cy (Table 3-1). This drop in rate was statistically more penetrant for actin-
Cdc8p cf. the mammalian tropomyosins (Table 3-1). Based on past studies with Myo2p 
and Cdc8p (Stark et al., 2010), this tropomyosin-mediated reduction in speed does not 
82	  	  
reflect inhibition per se, more so it reflects a Cdc8p-mediated bias for the strong actin-
bound ADP or apo states of Myo2p (Stark et al., 2010), states which are rate-limiting 
for myosin motility (Siemankowski et al., 1985). Consistent with such a positive effect, 
the presence of Cdc8p, Tpm3.1cy, and Tpm4.2cy increased the persistence and 
efficiency of Myo2p-driven filament gliding (Fig. 3-4A; Table 3-1). 
In contrast to the results obtained with Myo2p, decoration of actin with Cdc8p 
or the mammalian tropomyosins led to a much bigger reduction in SKMM-II-driven 
actin filament gliding speed (Table 3-1). While these reduced speeds varied statistically 
(between the different tropomyosins tested), they all reflected tropomyosin-mediated 
inhibition as the number of motile filaments and motility efficiency of SKMM-II was 
greatly diminished in the presence of each tropomyosin (Fig. 3-4B; Table 3-1). 
Recent studies have indicated that the use of saturating amounts of SKMM-II 
avoids tropomyosin-mediated inhibition of filament gliding (Barua et al., 2014).  
Nevertheless, we found that the inhibitory effects of the tropomyosins on motility speed 
and efficiency were still maintained when saturating concentrations of SKMM-II were 
employed (Figs. 3-5A and 3-5B). These contrasting results may reflect differences in 
the way SKMM-II preparations were attached to the slides in motility chambers. Barua 
et al. employed high salt to facilitate attachment of individual SKMM-II molecules, 
whereas we employed lower concentrations of salt to pre-assemble SKMM-II filament 
ensembles prior to attachment. 
In summary, while Cdc8p and the mammalian tropomyosins had an obvious 
positive effect on nonmuscle Myo2p motor function, these same tropomyosins potently 
inhibited SKMM-II motor function in the very same assays. 
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Differential Regulation of Myo52p and Myosin-Va by Mammalian Tropomyosins 
Myosin-Vs are transporters that typically operate as processive motors capable of taking 
multiple steps along actin filaments without falling off. Consequently, most myosin-V 
isoforms studied to date are high duty ratio motors, meaning that they spend a large 
proportion of their ATPase cycle in the strong actin-bound state. The high duty ratio 
and dimeric nature of these molecules facilitates processive, hand-over-hand walking 
along actin (De La Cruz et al., 1999; Mehta et al., 1999).  Mammalian myosin-Va 
represents a well-studied and highly processive form of myosin-V (De La Cruz et al., 
1999; Mehta et al., 1999). In contrast to myosin-Va, fission yeast Myo52p has a 
relatively low duty ratio for a myosin-V and is nonprocessive (Clayton et al., 2014; 
Clayton et al., 2010). Myo52p processivity and recruitment to actin cables in the cell 
relies on Cdc8p (Clayton et al., 2014). We wished to compare the ability of Cdc8p and 
the mammalian tropomyosins to regulate Myo52p and myosin-Va actin-activated 
ATPase activity and motility. Truncated heavy meromyosin (HMM) forms of Myo52p 
and myosin-Va were used that lack the C-terminal cargo-binding globular tail domain. 
These HMM forms represent dimeric myosin-V molecules possessing the motor 
domain, the light chain-binding region, and the coiled-coil region. 
Like Cdc8p, Tpm3.1cy, and Tpm4.2cy enhanced the activity of Myo52p motors 
in ATPase assays, as evidenced by a lower KM, higher VMAX, and greater overall 
catalytic efficiency compared to bare actin filaments (Fig. 3-2C; Table 3-1). Similar 
changes in Myo52p KM and VMAX values were also obtained in the presence of 
Cdc8p when using an alternative ATPase assay that utilizes an ATP-regenerating 
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system (Fig. 3-3B). This system avoids inhibitory build-up of ADP, which is common 
with high duty ratio motors like myosin-V. This assay revealed higher VMAX values 
for Myo52p, values closer to those one would predict from the Myo52p single molecule 
motility speeds previously reported from our laboratory (Clayton et al., 2014) (Fig. 3-
3B). 
We compared the effect of Cdc8p and the mammalian tropomyosins on myosin-
Va actin-activated ATPase activity utilizing the ATP-regenerating system (Fig. 3-2D). 
In contrast to the obvious effects seen with Myo52p (where the tropomyosins increased 
VMAX, reduced KM, and increased catalytic efficiency), the tropomyosins had little 
effect on myosin-Va activity. The presence of the three different tropomyosins (if 
anything) only slightly reduced the VMAX of myosin-Va, while having little effect on 
KM and catalytic efficiency values (Fig. 3-2D; Table 3-1). 
Similar to the effects of Cdc8p on Myo2p motility (Table 3-1), decoration of 
actin with Cdc8p significantly reduced the speed of Myo52p motility in filament gliding 
assays (Table 3-1). Consistent with the positive effect of the mammalian tropomyosins 
on Myo52p ATPase activity (Fig. 3-2C; Table 3-1), Tpm3.1cy and Tpm4.2cy had the 
same effect as Cdc8p and significantly reduced Myo52p actin gliding rate (Table 3-1). 
As seen with Myo2p, this drop in Myo52p motility rate was statistically more penetrant 
for actin-Cdc8p cf. the mammalian tropomyosins (Table 3-1). As with Myo2p, we 
predict that the reduced rates of gliding reflect the ability of tropomyosin to favor 
movement into the strong actin-bound state. In terms of motility efficiency, all three 
tropomyosins increased the frequency of Myo52p-driven filament gliding events (Table 
3-1), similar to the effect of the tropomyosins on Myo2p motility (Table 3-1). 
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In contrast to Myo52p, decoration of actin with Cdc8p or the mammalian 
tropomyosins had minor effects on myosin-Va-driven filament gliding (Table 3-1), 
consistent with the negligible effects of these tropomyosins on myosin-Va ATPase 
activity (Fig. 3-2D). While decoration of actin with Cdc8p did not alter myosin-Va 
gliding speed, decoration with Tpm3.1cy or Tpm4.2cy yielded minor increases in 
gliding speed (Table 3-1). The motility efficiency of myosin-Va was slightly improved 
in the presence of both Cdc8p and Tpm4.2cy, a feature which may reflect the wider 
distribution of motility rates observed with actin-Tpm3.1cy (Table 3-1). 
In summary, Cdc8p and the mammalian tropomyosins had an obvious positive 
effect on the nonprocessive Myo52p motor, whereas analysis of the same tropomyosins 
in the same assays revealed only minimal effects on the highly processive myosin-Va 
motor. Our previous work (Clayton et al., 2014) and the new findings with the 
mammalian tropomyosins implies that Cdc8p, Tpm3.1cy, and Tpm4.2cy favor the 
strong actin-bound state of myosin, which in turn favors an increase in the duty ratio of 
non-processive myosin-Vs. 
 
Activation of Fission Yeast Myosin-V Processivity by Mammalian Tropomyosins 
We previously used total internal reflection fluorescence (TIRF) microscopy to show 
that Cdc8p is required for single Myo52p motors to move processively along actin 
filaments (Clayton et al., 2014). We repeated these experiments to test whether the 
mammalian tropomyosins could also regulate Myo52p processivity. The Myo52p-
HMM employed had a C-terminal biotin tag for attachment to streptavidin-coated 
fluorescent quantum dots (Qdots) (Clayton et al., 2014). Fluorescently-labeled actin 
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filaments were attached to a glass coverslip, and a solution containing Myo52p-labeled 
with Qdots was applied. We assume our labeling approach achieves single molecule 
resolution based on optimization in previous studies (Clayton et al., 2014; Hodges et al., 
2009; Hodges et al., 2012). 
Consistent with our ATPase and filament gliding results, Tpm3.1cy and 
Tpm4.2cy behaved like Cdc8p and activated efficient processive movements of 
Myo52p along actin filaments (Figs. 3-6A and 3-6B; see Movies 3-S1 and 3-S2 in 
Supporting Information). The speeds and run lengths of these processive movements 
along Tpm3.1cy- and Tpm4.2cy-decorated actin tracks were in fact a little higher (Figs. 
3-6C and 3-6D) than those previously reported for Cdc8p-decorated tracks (speed: 
1.25  ±  0.43 µmŊs−1; run length: 0.64 µm) (Clayton et al., 2014).  The extent to which 
the different tropomyosin isoforms supported processivity varied with respect to run 
frequency. The run frequency with Tpm4.2cy was higher than with Cdc8p, while the 
frequency with Tpm3.1cy was lower than Cdc8p (Fig. 3-6E). In summary, the ability of 
Cdc8p to convert Myo52p to a processive motor is not restricted to yeast tropomyosin. 
This processivity can be accounted for by a tropomyosin-mediated increase in the 
myosin-V duty ratio. 
 
Mammalian Tropomyosin Tpm3.1cy can Function in Place of Fission Yeast Cdc8p In 
Vivo 
Fission yeast actomyosin contractile ring assembly, cytokinesis, and cell growth 
relies on both Myo2p motor activity and Cdc8p (Balasubramanian et al., 1992; Coffman 
et al., 2009; Kitayama et al., 1997; Lord et al., 2005; May et al., 1997; Stark et al., 
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2010). Likewise, recent studies highlighted an essential role for Tpm3.1cy in cancer cell 
proliferation (Stehn et al., 2013).  Given that Tpm3.1cy and Tpm4.2cy can function like 
Cdc8p in their ability to positively regulate Myo2p activity in vitro (Table 3-1), we 
wished to test whether either of these tropomyosins could function in place of Cdc8p in 
vivo. The ability of mammalian tropomyosin to support Cdc8p function is not 
unprecedented given that rat HMW tropomyosin Tm2 (Tpm1.6cy) can functionally 
substitute for Cdc8p in fission yeast (Balasubramanian et al., 1992). 
We tested whether Tpm3.1cy or Tpm4.2cy could rescue the lethal cytokinesis 
defects associated with loss of Cdc8p function in the temperature-sensitive cdc8-110 
mutant. While cdc8-110 cells carrying plasmids expressing (untagged) Cdc8p, 
Tpm3.1cy, or Tpm4.2cy all grew at the permissive growth temperature (25°C), only 
mutant cells expressing Cdc8p or Tpm3.1cy could sustain growth at the restrictive 
temperature (36°C) (Fig. 3-7A). Although GFP-Cdc8p and GFP-Tpm3.1cy were 
routinely found to concentrate at rings during cytokinesis, screening of many cells 
failed to detect any fluorescently-labeled rings upon GFP-Tpm4.2cy expression. Thus, 
Tpm4.2cy may simply fail to rescue cytokinesis in the cdc8-110 background owing to 
its failure to effectively target actin in the contractile ring (Fig. 3-7B). 
While contractile rings failed to assemble at 36°C in cdc8-110 cells harboring an 
empty vector control or Tpm4.2cy, cells expressing Cdc8p or Tpm3.1cy supported ring 
assembly and cytokinesis (Fig. 3-7C). Cdc8p and Tpm3.1cy restored normal 
actomyosin ring dynamics in cdc8-110 cells grown at the restrictive temperature (Fig. 
3-7D). The ring dynamics observed for cells expressing Cdc8p or Tpm3.1cy were 
similar to those of wild-type cells we have previously examined under these higher 
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temperature conditions (L. W. Pollard et al., 2012). Thus, at least in the case of 
Tpm3.1cy, mammalian tropomyosin function is suitably conserved to sustain 




Fission yeast tropomyosin Cdc8p localizes to contractile rings and actin cables where it 
positively regulates myosin-II and myosin-V respectively (Clayton et al., 2014; Clayton 
et al., 2010; Coulton et al., 2010; Stark et al., 2010). Such regulation has the potential to 
contribute to the spatial control of actomyosin function in more complex cellular 
environments where multiple isoforms of tropomyosin and myosin abound. In this study 
we demonstrate that Cdc8p and two mammalian nonmuscle LMW tropomyosins 
(Tpm3.1cy and Tpm4.2cy) differentially regulate myosin-IIs and myosin-Vs in a 
myosin isoform-specific manner (Fig. 3-8). We propose that myosin isoform-specific 
regulation reflects a general feature of certain nonmuscle tropomyosins. 
Interestingly, Tpm3.1cy successfully substituted for Cdc8p in vivo, supporting 
cytokinesis and cell growth. This finding suggests that Tpm3.1cy also shares functional 
similarity with the HMW isoform Tm2 (Tpm1.6cy)—the mammalian tropomyosin 
shown to substitute for Cdc8p in the original study on fission yeast tropomyosin 
(Balasubramanian et al., 1992).  Tpm3.1cy is essential for cancer cell proliferation and 
motility, and is beginning to show promise as a target for anti-cancer compounds (Stehn 
et al., 2013). The ability of Tpm3.1cy to positively regulate nonmuscle myosin function 
may contribute to its role in cancer cell viability. In contrast to Tpm3.1cy, Tpm4.2cy 
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could not function in place of Cdc8p in vivo. Given that Tpm3.1cy and Tpm4.2cy 
exhibit similar behaviors to Cdc8p in their abilities to regulate myosins, the short-
coming of Tpm4.2cy in vivo may simply reflect differences relating to other key actin-
binding proteins besides myosin. For example, unlike Cdc8p, Tpm4.2cy may not 
correctly protect actin filaments from severing by fission yeast ADF/cofilin Adf1p 
(Skau & Kovar, 2010), and/or fail to recognize and associate with formin- (Cdc12p-) 
nucleated actin filaments (Johnson et al., 2014). 
 
Positive Regulation of Nonmuscle Myosin Motors by Tropomyosins 
We previously demonstrated that Cdc8p promotes fission yeast Myo2p and 
Myo52p function by favoring movement into the strong actin-bound ADP/apo states 
(Clayton et al., 2010; Stark et al., 2010). This regulation increases the duty ratio of both 
myosins (Clayton et al., 2010; Stark et al., 2010), converting the nonprocessive Myo52p 
into a processive motor that can walk along the actin track as a single molecule 
(Clayton et al., 2014). Both of the mammalian tropomyosins tested were also capable of 
positively regulating Myo2p and Myo52p motor function. Both of these cytoplasmic 
tropomyosins converted Myo52p into a processive motor underscoring a conserved 
mechanism of regulation centered on positive modulation of the motor duty ratio. 
Collectively, our findings suggest that positive nonmuscle actomyosin 
regulation represents a conserved function of specific isoforms of tropomyosin. This is 
surprising given the large evolutionary distance between yeast and mammals reflected 
by the limited homology between tropomyosins from these two distinct systems. This 
regulation most likely reflects some conserved features of the tropomyosin sequence in 
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general, which appear to extend from human to yeast tropomyosins (Cranz-Mileva et 
al., 2013). Striated muscle α-tropomyosin/Tpm1.1st possesses a conserved periodic 
series of acidic and basic residues that establish association with actin (Barua et al., 
2013; Hitchcock-DeGregori et al., 2002; Singh et al., 2007), while other conserved 
acidic residues on the tropomyosin surface influence SKMM-II regulation (Barua et al., 
2012; Oguchi et al., 2011). These conserved acidic and basic residues are often found at 
the b, c, and f positions of the heptad repeats in the tropomyosin coiled-coil. These three 
positions are not involved with the folding and stability of the coiled-coil and are 
consequently available for association with other proteins. Similar conserved acidic and 
basic residues are also found at b, c, and f positions in Cdc8p and other fungal 
tropomyosins (Cranz-Mileva et al., 2013). Interestingly, amino acid substitutions at 
some of these sites in Cdc8p were recently found to compromise actin association and 
in vivo function (Cranz-Mileva et al., 2013). 
We speculate that the mammalian cytoplasmic tropomyosins we have studied 
can work like Cdc8p and facilitate positive regulation of myosins in mammals and other 
higher eukaryotes. Targets of such regulation likely include nonmuscle myosin-IIs, 
myosin-Vs, and potentially other classes of myosins that have yet to be tested. It will be 
interesting to further test the generality of this idea in the future. The influence here of 
other mammalian tropomyosins, such as other nonmuscle LMW isoforms, nonmuscle 
HMW isoforms, or striated muscle Tm1.1st may differ from Tpm3.1cy and Tpm4.2cy. 
 
Importance of the Myosin Isoform in Tropomyosin-Mediated Regulation 
The ability of Cdc8p and mammalian tropomyosins to promote nonmuscle 
myosin function breaks with the established role of tropomyosin in gating muscle 
91	  	  
myosin-II activity (Lehrer, 1994). In striated muscle, the troponin-tropomyosin complex 
initially assumes the “blocked” orientation on the actin filament which prevents 
interactions between myosin heads and actin. Ca2+-binding by troponin shifts 
tropomyosin into the “closed” position which allows limited binding between myosin 
heads and actin. However, once a myosin head binds actin it promotes further 
displacement of the tropomyosin molecule creating the “open” state facilitating 
cooperative binding of myosin heads nearby. Nevertheless, tropomyosins were 
obviously present in other cells and tissues long before muscle evolved. Thus, the role 
of tropomyosin in muscle is highly specialized and represents the exception rather than 
the rule. 
In the absence of troponin and Ca2+, tropomyosin-actin assumes the “closed” 
conformation (Lehman et al., 1994; Lehman et al., 2000).  Electron microscopy of actin 
filaments decorated with Cdc8p revealed that fission yeast tropomyosin also assumes 
the “closed” conformation (Skoumpla et al., 2007).  We found that the presence of 
Cdc8p or mammalian tropomyosins inhibited SKMM-II ATPase and actin filament 
gliding activities, despite the ability of these same tropomyosins to activate Myo2p and 
Myo52p under the same conditions. SKMM-II did show some residual activity in the 
presence of the tropomyosins in filament gliding assays, where the higher SKMM-II to 
actin ratios employed in such assays presumably facilitated some cooperative binding in 
this assay. Nevertheless, significant tropomyosin-mediated inhibition of SKMM-II was 
always observed even when these saturating concentrations of this myosin were 
employed in motility assays (Figs. 3-5A and 3-5B). 
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In some ways our results are consistent with previous studies assessing the 
influence of tropomyosins on SKMM-II activity (Fanning et al., 1994).  As we found 
with Tpm3.1cy and Tpm4.2cy, Fanning et al. saw that the presence of striated muscle 
Tm1.1st and nonmuscle HMW isoform Tpm4.1cy inhibited SKMM-II activity. In 
contrast to our findings, Fanning et al. observed increased SKMM-II activity in the 
presence of Tpm4.2cy. While the root of this discrepancy is not yet clear, it should be 
noted that our current study employed full-length SKMM-II that was included in 
experiments under low, physiological salt concentrations—conditions that yield 
SKMM-II filament formation. On the other hand, Fanning et al. employed the truncated 
S1 (subfragment 1) form of SKMM-II, which is unable to self-assemble at any salt 
concentration (as it only includes the motor domain and light chain-binding region of 
the myosin-II molecule). Nevertheless, consistent with the conflicting results of Fanning 
et al., Barua et al. (2014) observed increased rates of SKMM-II-driven actin filament 
gliding in the presence of both Tpm3.1cy and Tpm4.2cy (as pointed out earlier in our 
Results). However, unlike in our experiments, Barua et al. applied SKMM-II to motility 
chambers at a high salt concentration to facilitate antibody-based attachment of 
individual myosin molecules. We propose that the tropomyosins under study favor 
inhibition of SKMM-II ensembles, an effect that appears to be reversed when SKMM-II 
is prepared in its soluble, monomeric form. 
While Cdc8p, Tpm3.1cy, and Tpm4.2cy promote Myo52p function, none of the 
tropomyosins tested had a significant impact on the highly processive myosin-Va. 
Given that most class-V myosins studied to date are intrinsically processive, the ability 
of tropomyosins to positively regulate myosin-V may be restricted to non-processive 
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motors such as Myo52p (Clayton et al., 2014), budding yeast myosin-V (Hodges et al., 
2012), and other non-processive myosin-Vs found in higher eukaryotes (Takagi et al., 
2008; Toth et al., 2005; Watanabe et al., 2008). 
In summary, tropomyosin-mediated regulation of SKMM-II and the nonmuscle 
myosins underscores how actin-tropomyosin can specify different motor outputs (Fig. 
3-8). The “closed” actin-tropomyosin conformation appears to be capable of myosin 
activation (Myo2p and Myo52p) or inhibition (SKMM-II and type-I myosins), while at 
the same time acting passively on other myosins (myosin-Va). This differential 
regulation has broad implications for understanding how myosin activity can be sorted 
at specific tropomyosin-actin structures in time and space in complex systems, such as 
developing muscle tissue or metastatic cancer cells. 
 
Materials and Methods 
Bacterial Plasmids 
Tropomyosin constructs were used to overexpress acetylated-mimicking forms 
of the protein in E. coli. The cdc8 gene was PCR-amplified from Schizosaccharomyces 
pombe cDNA using the following primers: 5' NdeI-cdc8 
CAATCATATGGCTAGCATGGATA-AGCTTAGAGAG (the NdeI site is italicized, 
and the start codon of the cdc8 ORF is underlined) and 3' BamHI-cdc8 
CAATGGATCCCTACAAGTCC-TCAAGAGCTT (the BamHI site is italicized, and 
the cdc8 stop codon is underlined). The 5' primer includes encodes an Ala-Ser 
(acetylation-mimicking) dipeptide immediately upstream of the cdc8 start codon. The 
start codon for the recombinant protein actually lies in the second half of the NdeI site 
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allowing for incorporation of the Ala-Ser codons. Mammalian tropomyosin constructs 
were made in an identical fashion using human Tpm3.1cy and Tpm4.2cy cDNAs as 
templates. Cdc8p and Tpm3.1cy plasmids lacking the Ala-Ser dipeptide were also 
constructed. Each oligonucleotide was individually cloned into the pET3 vector and 
fidelities confirmed by DNA sequencing. 
 
Fission Yeast Plasmids and Strains 
Untagged and N-terminally GFP-tagged versions of Cdc8p and the mammalian 
tropomyosins were expressed in fission yeast strains using the pREP-41x and pDS573a-
41x vectors respectively. These ura4+ plasmids utilize the inducible nmt1-41x (medium 
strength) promoter which drives expression in the absence of thiamine. The cdc8 gene 
was PCR-amplified from S. pombe cDNA using the following primers: 5' NotI-cdc8 
GCGG-CCGCATGGATAAGCTTAGAGAGGTATGAG (the NotI site is italicized, 
and the start codon of the cdc8 ORF is underlined) and 3' SalI-cdc8 GT-
CGACCTACAAATCCTCAAGAGCTTGGTGA-AC (the SalI site is italicized, and the 
cdc8 stop codon is underlined). The cdc8 gene was inserted into NotI/SalI linearized 
pREP-41x and pDS573a-41x. Mammalian tropomyosin constructs were made in an 
identical fashion using human Tpm3.1cy and Tpm4.2cy cDNAs as templates. The 
fidelities of inserts was confirmed by DNA sequencing. 
Untagged tropomyosins were expressed in a temperature-sensitive cdc8-110 
mutant (h- leu1-32 ura4-D18 his3-D1 ade6-M216 cdc8-110 rlc1-mYFP:kanR) mutant, 
while GFP-tagged tropomyosins were expressed in wild-type (h− leu1-32 ura4-D18 
his3-D1 ade6-M216 uch2-mCherry:natR) cells. The rlc1-mYFP and uch2-mCherry 
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genomic integrations were constructed by standard techniques using the appropriate 
kanamycin-resistant kanR and nourthreothricin-resistant natR casettes (Bahler et al., 
1998; Snaith et al., 2010). 
 
Protein Purification 
Full-length fission yeast Myo2p was overexpressed and purified as previously 
described (Lord et al., 2004). Chicken skeletal muscle myosin-II was purified using 
standard techniques (Kielley et al., 1960). Recombinant HMM forms of fission yeast 
Myo52p and mammalian (chick brain) myosin-Va were overexpressed in the 
Baculovirus/Sf9 insect cell system and purified as previously described (Clayton et al., 
2014; Krementsov et al., 2004). Biotin was included in the cell culture media to ensure 
full biotinylation of biotin-binding tags engineered at the C-terminus of the HMMs. 
Additional myosin-V light chains were purified following overexpression in bacteria 
(see below) (Clayton et al., 2014; Krementsov et al., 2004). Chicken skeletal muscle 
actin was employed throughout and purified from acetone powder as previously 
described (Spudich & Watt, 1971). 
Tropomyosin and myosin-V light chain (Cam1p, Cdc4p, and CaMΔall) proteins 
were produced in E. coli BL21 DE3 competent cells. Cultures were grown in LB media 
at 37°C and protein overexpression induced at an OD600 of 0.5 by addition of 0.4 mM 
IPTG. Cells were harvested following overnight induction at 25°C. Proteins were 
purified as described previously (Krementsov et al., 2004; Pruyne et al., 1998). Cell 
pellets were resuspended in lysis buffer (100 mM NaCl, 10 mM imidazole, pH 7.2, 2 
mM EDTA, and 1 mM DTT) and sonicated. Lysates were boiled for 10 min while 
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stirring, then pelleted to remove denatured protein and other debris. Soluble 
tropomyosins (or light chains) were precipitated from the supernatant by lowering the 
pH to 0.2 units below the isoelectric point of the relevant protein. The protein 
precipitate was resuspended in 50 mM NaCl, 1 mM DTT, 10 mM imidazole, pH 7.4, 
and dialyzed for three rounds (3 inline image 1 L) against the same buffer, followed by 
addition of 5 µg/ml leupeptin. 
 
Actin-Activated ATPase Assays 
Standard actin-activated ATPase assays were carried out at room temperature 
using the Malachite green assay to quantitate Pi release (Henkel et al., 1988). This 
approach was employed to assay Myo2p, SKMM-II, and Myo52p-HMM. Reactions 
were carried out in 2 mM Tris-HCl, 10 mM imidazole, pH 7.2, 60 mM KCl, 0.1 mM 
CaCl2, 3 mM MgCl2, 2 mM ATP, and 1 mM DTT. Colorimetric measurements were 
taken at 595 nm in a plate reader. In addition, actin-activated ATPase assays were 
carried out at room temperature using an ATP-regenerating system to assay Myo52p-
HMM and myosin-Va-HMM. Reactions in this NADH-linked assay were carried out in 
10 mM imidazole, pH 7.4, 50 mM KCl, 4 mM MgCl2, 1 mM EGTA, and 1 mM DTT. 
Reactions were initiated by the addition of 2 mM Mg2+-ATP. The buffers also 
contained an ATP regenerating system (0.5 mM phosphoenolpyruvate, 100 units/ml 
pyruvate kinase), 0.2 mM NADH, and 20 units/ml lactate dehydrogenase. The rate of 
the reaction was measured from the decrease in absorbance at 340 nm. 
The assays included 30 nM Myo2p, 90 nM SKMM-II, 10 nM Myo52p-HMM 
(with excess 350 nM Cam1p and Cdc4p light chains), or 14 nM myosin-Va-HMM (with 
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excess 350 nM calmodulin), plus 0–30 µM actin/actin-tropomyosin filaments. Actin 
was pre-incubated with the different tropomyosins at a 2:1 molar ratio 60 min prior to 
dilution. Curves were fit to Michaelis-Menten kinetics using Kaleidagraph software. 
 
In Vitro Actin Filament Gliding Assays 
We used motility assays based on an established protocol (Kron et al., 1986). 
Myosins under study were delivered into motility chambers at the following 
concentrations: Myo2p, 5 nM; SKMM-II, 5 nM; Myo52p-HMM, 27 nM; and myosin-
Va, 21 nM. Higher concentrations of SKMM-II were also tested (10 and 50 nM); 5 µM 
stocks of fluorescent actin were polymerized by addition of 50 mM KCl and 1 mM 
MgCl2 incubated for 30 min, and then labeled with 5 µM of rhodamine phalloidin for 
30 min. After myosins were adhered to the surface of a nitrocellulose-coated cover-slip 
for 10 min, the chamber was washed: (a) 3× with Motility Buffer (25 mM imidazole, 
pH 7.4, 50 mM KCl, 1mM EGTA, 4 mM MgCl2, 2 mM DTT) plus 0.5 mg/ml BSA. 
Excess light chains were also included in this buffer for experiments with Myo52p-
HMM (14 µM of Cam1p and Cdc4p) and myosin-Va-HMM (14 µM of calmodulin), (b) 
3× with Motility Buffer alone, (c) 2× with Motility Buffer containing 1 µM of vortexed 
(30 s) unlabeled actin filaments, (d) 3× with Motility Buffer plus 1 mM ATP, (e) 2× 
with Motility Buffer plus 25 nM rhodamine phalloidin-labeled actin filaments and 
oxygen scavengers (50 µg/ml catalase, 130 µg/ml glucose oxidase, and 3 mg/ml 
glucose), (f) twice with Motility Buffer plus 20 mM DTT, 0.5% methyl-cellulose, and 
scavengers, and (g) twice with Motility Buffer plus 20 mM DTT, 0.5% methyl-
cellulose, 1.5 mM ATP, and scavengers. To limit actin-tropomyosin dissociation, 
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washes (e–g) included 10 µM tropomyosin for assays with decorated filaments. 
Filaments were observed at room temperature by epi-fluorescence microscopy and 
recorded at intervals of 1 s for 1 min. Image J software was used to calculate filament 
velocities from time-lapse series (n  =  35–150 filaments). 
 
Tracking Myo52p-Qdot Motility by TIRF Microscopy 
Myo52p-HMM (0.2 µM) was mixed with a twofold molar excess of actin and 2 
mM Mg2+-ATP, and centrifuged for 20 min at 400,000 × g to remove any myosin that 
was unable to dissociate from actin in the presence of ATP. To investigate processivity 
of individual myosin V motors, Myo52p was then mixed with a 10-fold molar excess of 
655 nm streptavidin-coated Qdots (Invitrogen). In principle, a small fraction of Qdots 
will have two or more motors bound, but previous controls demonstrated that Qdots are 
driven primarily by a single motor at this mixing ratio (Hodges et al., 2012). Flow cells 
made from glass coverslips were prepared by introducing the following solutions into 
the flow cell: 0.1 mg/ml N-ethylmaleimide-modified skeletal muscle myosin (5 min 
incubation), 5× rinse of 1 mg/ml BSA (2 min), 2 µM rhodamine-phalloidin-labeled 
chicken skeletal muscle actin filaments (plus or minus 1 µM tropomyosin) (2–5 min), 
5× rinse with motility buffer, and, finally 0.2 nM Myo52p in motility buffer with 2 mM 
MgATP. Motility buffer consists of 50 mM KCl, 25 mM imidazole, pH 7.4, 4 mM 
MgCl2, 1 mM EGTA, 50 mM DTT, 1 mg/ml BSA, 3.5 µM Cam1p, 3.5 µM Cdc4p, and 
an oxygen-scavenging system (3 mg/ml glucose, 0.1 mg/ml glucose oxidase, and 0.18 
mg/ml catalase). For experiments with tropomyosin, 1 µM tropomyosin was included in 
the motility buffer to prevent dissociation from actin. 
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Through-the-objective TIRF microscopy was performed at room temperature 
using the Nikon Eclipse Ti-U microscope equipped with a 100× Plan Apo objective lens 
(1.49 NA) and auxiliary 1.5× magnification. Fluorophores were excited with a 473 nm 
(Qdots) laser line and images were obtained using the XR/Turbo-Z camera (Stanford 
Photonics) running Piper Control software (v2.3.39). The pixel resolution was 95.0 nm, 
and data were collected at 5 to 30 frames per second. Qdot movement along rhodamine-
labeled actin filaments was tracked by hand using ImageJ. For each event, we required 
Qdot-labeled Myo52p to move continuously for at least three frames to qualify as a run. 
Runs that artificially terminated by running off the end of an actin filament were not 
included in the run length analysis. 
 
Live Cell Imaging 
DIC and epi-fluorescence cell images were captured using a Nikon TE2000-E2 
inverted microscope with motorized fluorescence filter turret and a Plan Apo 60× (1.45 
NA) objective. Fluorescence utilized an EXFO X-CITE 120 illuminator. NIS Elements 
software was used to control the microscope, two Uniblitz shutters, a Photometrics 
CoolSNAP HQ2 14-bit camera, and auto-focusing. Still images (GFP-tropomyosins, 
Rlc1-YFP) or time-lapse images (Rlc1p-YFP) of contractile rings were generated using 
the appropriate filters. For ring movies, images were captured every 2 min and 
autofocusing was performed on the DIC channel before each capture. Cell suspensions 
(3 µl) were mounted on flat 30 µl EMM media pads (solidified by 1% agarose) prepared 
on the slide surface. VALAP (1:1:1 vasoline, lanolin, and paraffin) was used to seal 
slides and cover-slips. Images were captured using Nikon ND software and analysis of 
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ring dynamics was performed using Image J and Microsoft Excel software. Ring 
dynamics were quantified by assessing individual phases: assembly, time taken for 
Rlc1p-YFP to compact into a mature ring following its appearance as a broad band of 
nodes; dwell, time from completion of ring compaction until initiation of constriction; 
constriction, change in ring circumference over time. Dwell times and constriction 
initiation were discerned by plotting ring diameter over time for each ring, and 
circumferential ring constriction rates were derived from the slopes of these plots. 
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Table 3-1. Effect of Cdc8p and the mammalian tropomyosins on the motor activity 
and motility of Myo2p, SKMM-II, Myo52p, and myosin-Va 
Table summarizes how tropomyosins Cdc8p, Tpm3.1cy, and Tpm4.2cy influence 
myosin motor performance.  
 
aMyo2p, SKMM-II, Myo52p, and myosin-Va actin-activated ATPase values were 
generated from the average curves presented in Figure 2A–D. Assays utilized a 
malachite green-based Pi detection system, except for myosin-Va where an ATP-
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regenerating-based ATPase assay was employed (see Supplemental Proceduresfor 
further details). Datasets: n=4 (Myo2p and Myo52p), n=3 (SKMM-II), and n=1 
(myosin-Va). 
bCatalytic efficiency = VMAX/KM. 
cn=50–150. Paired Student’s t-tests were used to test the significance of the 
tropomyosin-mediated changes in actin filament gliding rate versus actin alone (p <0.05 
indicates a significant difference between datasets). All tropomyosins significantly 
reduced the gliding rates of Myo2p (Cdc8p, <0.0001; Tpm3.1cy, <0.0001; Tpm4.2cy, 
<0.0001), SKMM-II (Cdc8p, <0.0001; and Tpm3.1cy, <0.0001; Tpm4.2cy, <0.0001), 
and Myo52p (Cdc8p, <0.0001; and Tpm3.1cy, <0.0001; Tpm4.2cy, <0.0001). However, 
in the case of myosin-Va, two out of the three tropomyosins tested (Tpm3.1cy and 
Tpm4.2cy) yielded a significant increase in gliding rate, while Cdc8p had no significant 
effect (Cdc8p, 0.756; Tpm3.1cy, 0.036; Tpm4.2cy, 0.0006). We performed additional 
statistical analyses to gauge any significant differences between the effects of the three 
different tropomyosins on motility. For Myo2p, there was significant difference for 
Cdc8p vs. Tpm3.1cy (0.02) and Cdc8p vs. Tpm4.2cy (0.0015), but no significant 
difference for Tpm3.1cy vs. Tpm4.2cy (0.15). For SKMM-II, there were significant 
differences between all of the tropomyosins (<0.0001 for all combinations). For 
Myo52p, there was significant difference for Cdc8p vs. Tpm3.1cy (0.0002) and Cdc8p 
vs. Tpm4.2cy (0.0139), but no significant difference for Tpm3.1cy vs. Tpm4.2cy 
(0.0786). For myosin-Va, there was significant difference for Cdc8p vs. Tpm3.1cy 
(<0.0001) and Tpm3.1cy vs. Tpm4.2cy (0.0004), but no significant difference for 
Cdc8p vs. Tpm4.2cy (0.183). 
dRelative number of motile (myosin-driven) actin filaments/total actin filaments. A total 
of five different movie fields were scored for each sample at a set concentration of 





Figure 3-1. Tropomyosins under study. A) Schematic illustration summarizing exon 
usage by mammalian tropomyosin TPM3 and TPM4 gene products Tpm3.1cy and 
Tpm4.2cy. While the two proteins are the products of two different genes, their exon 
usage makes these two LMW tropomyosins very similar. The only obvious difference 
being that Tpm3.1cy employs exon 6a, while Tpm4.2cy employs exon 6b. B) Purified 
protein samples following SDS-PAGE and gel staining with Coomassie Blue. 
Molecular weights are included on the left. Cdc8p and the mammalian tropomyosins 
were purified from bacteria (acetylation-mimicking forms including the Ala-Ser 




Figure 3-2. Regulation of Myo2p, SKMM-II, Myo52p, and myosin-Va motor 
activity by tropomyosin. The actin-activated Mg2+-ATPase activity of Myo2p, 
SKMM-II, Myo52p, and myosin-Va was measured as a function of actin or actin-
tropomyosin concentration. Basal myosin ATPase activities and background Pi from 
actin or actin-tropomyosin were subtracted from all measurements. Each average curve 
fit presented was generated from average values obtained from 4 (Myo2p and Myo52p), 
3 (SKMM-II), and 1 (myosin-Va) dataset(s). A) Myo2p, B) SKMM-II, C) Myo52p, and 
D) myosin-Va ATPase activities compared with and without Cdc8p, Tpm3.1cy, and 
Tpm4.2cy. All the values are summarized in Table 1. The myosin concentrations in 
these assays were: 30 nM (Myo2p), 90 nM (SKMM-II), 10 nM (Myo52p), and 14 nM 
(myosin-Va). Actin filaments were preincubated with tropomyosin at a molar ratio of 2 
actin:1 tropomyosin. The Myo2p, SKMM-II, and Myo52p curves were generated from 
data measured using a malachite green-based Pi detection assay. The myosin-Va curves 
were generated from data measured using an NADH-linked-/ATP-regenerating-based 
ATPase assay. Myo52p curves generated using the ATP-regenerating-based assay are 
provided in Fig. 3B.  
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Figure 3-3. Assessment of tropomyosin acetylation on SKMM-II inhibition and 
Cdc8p-mediated activation of Myo52p in actin-activated ATPase assays. A) The 
influence of acetylated-mimicking versus unacetylated forms of both Cdc8p and 
Tpm3.1cy on the actin-activated ATPase activity of SKMM-II were compared in 
parallel (in the same fashion as the SKMM-II experiments described in Fig. 2). The 
fitted values for each condition are the averages from two independent experiments. B) 
The Myo52p VMAX values obtained from ATPase assays employing malachite green-
based Pi detection (Fig. 2C; Table 1) were lower than what we would predict from the 
speeds at which single Myo52p molecules move on Cdc8p-decorated actin tracks 
(Clayton et al., 2014). Assuming Myo52p has a 36 nm step size similar to other myosin-
Vs (Trybus, 2008), a single Myo52p molecule must take ∼35 steps per second to 
achieve the average speed (1.25 µm/s) of Myo52p on Cdc8p-actin tracks (Clayton et al., 
2014). This rate of 35 s−1 is approximately fivefold higher than what we obtained (∼7 
s−1) from our ATPase data (Table 1). In light of these observations we employed an 
alternative assay that utilizes an ATP-regenerating system to avoid any inhibitory build-
up of ADP. This assay revealed a higher VMAX of 52 s−1 for Myo52p, closer to the 35 
s−1 predicted from single molecule studies. Nevertheless, the general trend of 
tropomyosin-mediated activation of Myo52p remained the same: the presence of Cdc8p 
on actin increased the VMAX from 45 to 52 s−1 (compared with 4.7 to 6.6 s−1 in our 
original assays; Table 1) and significantly reduced the KM from 22 to 5 µM (compared 
with 9.3 to 2.8 s−1 in our original assays; Table 1). The steady-state actin-activated 
ATPase activity of Myo52p was measured as a function of actin concentration (actin 
alone: open circles; actin plus Cdc8p: filled circles). Myo52p was included in the assays 
at a concentration of 10 nM. Lines are fits to Michaelis-Menten kinetics. The 




Figure 3-4. Regulation of Myo2p- and SKMM-II-driven actin filament gliding by 
tropomyosin. The efficiency of myosin-driven actin filament gliding is portrayed using 
representative fields of (rhodamine-phalloidin labeled) filaments generated from time-
lapse epi-fluorescence microscopy experiments. Images shown are maximum 
projections of 60 frames captured every second for both Myo2p (A) and SKMM-II (B). 
Myo2p and SKMM-II were employed at a working concentration of 5 nM (the same 
concentration used to generate the filament gliding data presented in Table 1). The 
trajectory of filament movement over time is tracked and summarized by marking (with 
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colored circles for each frame) the leading ends of any filament exhibiting motility 
during the movies. Trajectories of filament motility were compared for bare actin and 
the indicated tropomyosin-decorated filaments. A) The motility events for Myo2p with 
bare actin filaments are a little faster (circles slightly further apart) yet shorter in 
duration (shorter trajectory length) compared with the events tracked with actin-
tropomyosin filaments. This reflects the slightly slower yet more continuous and 
efficient filament motility observed for Myo2p with tropomyosin-actin filaments. 
(Table 1). B) The motility events for SKMM-II with bare actin filaments are much 
faster (circles an obvious distance apart), more numerous, and more longer lived 
compared with the events tracked with actin-tropomyosin filaments. This reflects the 
much slower and much less efficient filament motility observed with tropomyosin-actin 
filaments (where many more filaments associated with the coverslip surface are non-
motile or fail to sustain persistent motility) (Table 1). The speeds and efficiencies of 
SKMM-II-driven actin filament gliding were also compared with and without 




Figure 3-5. Effect of tropomyosin on SKMM-II-driven actin filament gliding in 
relation to myosin concentration. The working concentration of SKMM-II employed 
in our actin filament gliding assays (Fig. 4B; Table 1) was 5 nM (2.5 µg/ml). We also 
compared the motility activity of SKMM-II at higher myosin concentrations. A) The 
effect of saturating SKMM-II (50 nM/25.0 µg/ml) was tested with bare actin filaments 
versus Cdc8p-, Tpm3.1cy-, or Tpm4.2cy-decorated filaments. The histogram 
summarizes the SKMM-II filament gliding rates (n  =  30–70 filaments per experiment). 
B) Histogram summarizing SKMM-II gliding efficiency versus myosin concentration 
with bare actin filaments versus Cdc8p-decorated filaments. Gliding efficiency reflects 
the number of motile (myosin-driven) actin filaments/total actin filaments. A total of 
two to five different movie fields were scored. The relative number of motile filaments 




Figure 3-6. Regulation of Myo52p processivity by tropomyosin. Processive 
movement of Myo52p-HMM molecules coupled to Qdots along tropomyosin-decorated 
rhodamine phalloidin-labeled actin filaments using TIRF microscopy. A) Movement of 
a Myo52p-Qdot (green) along Tpm3.1cy- and Tpm4.2cy-decorated actin filaments 
(red). Bars: 4 µm. Representative events are presented in Supporting Information 
Movies S1 and S2. B) Kymographs of processive runs of Myo52p-HMM along actin 
filaments decorated with Tpm3.1cy and Tpm4.2cy. C) Histograms of the speed 
distributions for processive Myo52p runs along actin filaments decorated with 
Tpm3.1cy and Tpm4.2cy. D) Run length histograms for Myo52p movements along 
actin filaments decorated with Tpm3.1cy and Tpm4.2cy. The red curves show 
exponential fits (y  =  Ae−x/λ) to determine the run length λ. E) Histogram comparing the 
frequencies of processive Myo52p runs on actin filaments decorated with Cdc8p, 
Tpm3.1cy, or Tpm4.2cy. Frequency values reflect the number of Myo52p events (runs) 
observed per µm of actin-tropomyosin filament track available over time. Final values 





Figure 3-7. Mammalian tropomyosin Tpm3.1cy rescues Cdc8p function in vivo. 
The ability of Tpm3.1cy or Tpm4.2cy to substitute for Cdc8p during cytokinesis was 
tested in fission yeast. Tropomyosin (either untagged or GFP-tagged) expression was 
driven from the inducible nmt41x promoter in fission yeast plasmids (see Experimental 
Procedures for details). A) Temperature-sensitive cdc8-110 cells were transformed with 
various ura4+ plasmids and isolated under permissive growth conditions (25°C) on 
EMM-Ura− minimal media plates. The plate shown indicates the ability/inability of the 
different plasmids to rescue Cdc8p function. Here transformants were grown on EMM-
Ura− plates at the restrictive temperature (36°C) to attenuate Cdc8-110p function and 
select for rescue. The plates contained 5 µg/ml phloxin B, a pink dye that accumulates 
inside dead cells (note the darker pink color of the cell streaks that failed to grow). 
Plasmids harbored untagged cdc8 (positive control), cDNAs for Tpm3.1cy or 
Tpm4.2cy, or lacked an insert altogether (empty vector, negative control). B) Images of 
wild-type cells expressing GFP-tagged versions of Cdc8p, Tpm3.1cy, or Tpm4.2cy 
were captured during cytokinesis. The strain background includes a uch2-mCherry 
fusion integrated into the chromosome to mark dividing/divided nuclei. Cells were 
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grown in EMM-Ura- minimal media at 30ºC. Scale bar: 4 µm. C) DIC and fluorescence 
images of cdc8-110 cells expressing untagged Cdc8p (left) or Tpm3.1cy (center). 
Control cells carrying an empty vector are also shown (right). Cells were grown at 36°C 
in EMM-Ura- minimal media, and Rlc1p-YFP contractile ring structures visualized via 
an integrated rlc1-mYFP fusion. Scale bar: 4 µm. D) Plots charting the assembly, dwell, 
and constriction phases of individual ring diameter traces (red, n  =  25) from cdc8-110 
cells expressing untagged Cdc8p (left) or Tpm3.1cy (right). The thick black lines reflect 
average fits of all the individual ring traces. Ring dynamics were recorded using time-
lapse epi-fluorescence microscopy of Rlc1p-YFP. For each plot the length of flat line 
traces shown at negative time represent the assembly phase, while the line traces shown 
at positive time correspond to ring diameter during the dwell (preconstriction) and 
constriction phases. Cells were grown as described in C. Average assembly times, dwell 





Figure 3-8. Model depicting differential regulation of myosins by the “closed” 
actin-tropomyosin state. The “closed” state reflects the position of Cdc8p and other 
tropomyosins bound along actin filaments in the absence of troponin. While referred to 
as “closed,” this state can act positively, negatively, or passively on myosins depending 
on the myosin isoform. Such features offer the potential for tight spatial regulation of 




Supplementary Movie Legends 
 
Movie 3-S1. Tpm3.1cy-decorated actin filaments support the processive movement 
of Myo52p-Qdots. 
Myo52p-HMM-Qdots can move processively on Tpm3.1cy-decorated actin filaments. 
Data were collected using TIRF microscopy with a capture rate of 30 frames/s and are 
played back at this speed. Scale bar: 2 µm. 
 
Movie 3-S2. Tpm4.2cy-decorated actin filaments support the processive movement 
of Myo52p-Qdots. 
Myo52p-HMM-Qdots can move processively on Tpm4.2cy-decorated actin filaments. 
Data were collected using TIRF microscopy with a capture rate of 30 frames/s and are 






CHAPTER 4.  DISCUSSION 
The work presented in this dissertation describes differential regulation of 
myosin by non-muscle tropomyosin.  Chapter 2 describes single molecule in vitro 
experiments and fission yeast based in vivo studies that demonstrate enhancement of 
type V myosin activity by tropomyosin.  The sole fission yeast tropomyosin Cdc8 
enables processive movement of the low duty ratio motor Myo52.  Multiple Myo52 
motors bound to a Qdot also require Cdc8 for continuous transport.  This finding 
indicates regulation of Myo52 by Cdc8 is relevant within the context of the fission yeast 
cell, which relies on multiple Myo52 motors to transport cargo.  Decoration of actin 
tracks with tropomyosin provides a simple mechanism to sort myosin motors to 
particular actin structures that could be relevant in higher eukaryotes that express 
nonprocessive type V myosins (Takagi et al., 2008; Toth et al., 2005; Watanabe et al., 
2008) and a larger set of tropomyosin isoforms (Gunning, Hardeman, et al., 2015). 
Previous biochemical studies indicate that Myo52 is a low duty ratio motor 
incapable of processive movement (Clayton et al., 2010).  Enabling Myo52 processivity 
requires increasing the duty ratio of the motor to greater than 50% either by increasing 
the percentage of cycle time in the strong-bound states or decreasing the time in the 
weakly bound states.  The observed decrease in Myo52 KM and decrease in filament 
gliding speed with Cdc8 indicates that tropomyosin increases the percentage of time the 
motor spends in the strong-bound state (Clayton et al., 2010).  The increase in Myo52 
Vmax achieved with Cdc8 suggests that Cdc8 also decreases the total cycle time of the 
motor.  However, these effects appear to be myosin V isoform specific.  The budding 
yeast type V myosin, Myo2p, requires tropomyosin for processive movement, although 
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tropomyosin does not affect the actin affinity or Vmax of this myosin V (Hodges et al., 
2012).  Steady-state enzyme kinetics experiments indicate that tropomyosin dependent 
processive movement of Myo2p is achieved by decreasing the rate of ADP release and 
dissociation from actin (Hodges et al., 2012).  
Myo52 single molecule experiments at low ATP concentrations demonstrate 
that increasing the Myo52 strong actin-bound state is sufficient to achieve processive 
movement.  The favoring of the nucleotide-free rigor state at low ATP increases the 
duty ratio of Myo52 to over 95% with or without tropomyosin.  However, under these 
conditions, the addition of Cdc8 resulted in a seven-fold increase in the number of 
Myo52 processive events and longer average run lengths compared to undecorated 
actin.  These results indicate tropomyosin regulates Myo52 through a mechanism that is 
in addition to increasing the duty ratio of the motor.  The increased Myo52 run length 
with tropomyosin-decorated actin may be explained by an improved gating between the 
two Myo52 heads – possibly by slowing ADP release in response to tropomyosin 
induced strain on the motor domain (Geeves et al., 1999).  Additionally, a 6.5 Å 
structure of the actin-tropomyosin complex determined by cryo-electron microscopy 
illustrates direct interactions between tropomyosin and myosin (von der Ecken et al., 
2015).  Contacts between tropomyosin and myosin may increase motility efficiency by 
increasing myosin affinity for the actin filament or by decreasing the amount of time the 
advancing myosin head searches for the next actin-docking site.   
Clustering of truncated Myo52 motors on actin cables observed in vivo suggests 
cooperative binding of myosin heads on tropomyosin-decorated actin.  A similar 
mechanism regulates actomyosin in striated muscle, in which a high concentration of 
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ordered type II myosin activates the actin thin filament by shifting tropomyosin from 
the inhibitory “closed” state to the fully accessible “open” state (VanBuren et al., 1999).  
Cryo-electron microscopy of Cdc8 decorated actin showed that these filaments assume 
the “closed” state (Skoumpla et al., 2007) (Figure 4-1).  Consistent with this 
observation, Cdc8-decorated actin inhibits skeletal muscle myosin activity (East, Sousa, 
et al., 2011).  However, Myo52 processive motility was observed at low concentrations 
of Myo52 in single molecule assays, demonstrating that either the “closed” state of 
Cdc8-actin filaments is not inhibitory to this myosin, or single molecules of Myo52 are 
able to shift the tropomyosin filament to the “open” state.  
 
The broader implications of actomyosin regulation by tropomyosin were 
explored in chapter 3.  Two tropomyosin isoforms associated with cancer cell 
transformation (Tpm3.1 and Tpm4.2) were tested for the ability to regulate type II and 
type V myosin.  Both Tpm3.1 and Tpm4.2 decorated actin filaments enhanced Myo52 
activity and enabled Myo52 processive motility comparable to that achieved with Cdc8 
decorated actin.  Tpm3.1 and Tpm4.2 also enhanced type II non-muscle myosin activity 
(Myo2), while skeletal muscle myosin II was starkly inhibited by these tropomyosins.  
The increase in Myo2 activity with Tpm3.1 and Tpm4.2 is consistent with the increased 
non-muscle myosin II activity observed during cytokinesis in higher eukaryotes over-
expressing Tpm1.8 (Eppinga et al., 2006). The highly processive MyoVa was largely 
unaffected by Tpm3.1 and Tpm4.2, indicating that positive regulation of type V 
myosins may be limited to non-processive motors.  Activation of type V myosins may 
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be an important form of regulating myosin motor output in higher eukaryotes that 
express non-processive myosin V, including human myosin Vc (Takagi et al., 2008). 
The similarity of tropomyosin function between yeast and mammalian isoforms 
is unexpected given the large evolutionary distance between these organisms.  This is 
likely due to conserved characteristics of the tropomyosin sequence that determine its 
association with actin and myosin.  Striated muscle tropomyosin Tpm1.1 associates 
with actin via a periodic series of acidic and basic residues predominantly at locations b, 
c, and f of the heptad repeats (Barua et al., 2013; Hitchcock-DeGregori et al., 2002).  
Highlighting a conserved feature among tropomyosins, amino acid substitutions made 
to Cdc8 at similar acidic residues at locations b, c, and f disrupted association with actin 
and in vivo function (Cranz-Mileva et al., 2013).   
Conserved features of tropomyosin notwithstanding, considerable differences 
exist between the sequence and size of Cdc8 versus mammalian tropomyosins.  It is 
therefore unexpected that Tpm3.1 successfully substituted for Cdc8 in vivo, resulting in 
Tpm3.1 dependent fission yeast cells exhibiting comparable cytokinesis kinetics and 
growth rates to wild type cells.  Transformed neuroblastoma and melanoma cells 
depend on Tpm3.1 for proliferation, potentially providing an effective target for anti-
cancer therapies.  Small molecule compounds are being developed that bind to the 
Tpm3.1 C-terminus, altering the Tpm3.1 filaments (Stehn et al., 2013).   
Tpm4.2 and Tpm3.1 are the products of similar exon arrangements, although 
Tpm4.2 derives from the use of exon 6b while Tpm3.1 uses exon 6a.  Despite sequence 
similarities to Tpm3.1 and exhibiting an ability to regulate type II and type V myosins 
comparable to Tpm3.1 and Cdc8, Tpm4.2 was unable to replace Cdc8 in vivo.  This 
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finding may be explained by sequence variations between the TPM3 and TPM4 genes, 
or an effect determined by exon 6. Small differences in the sequence or structure of 
Tpm3.1 and Tpm4.2 could alter the ability of these tropomyosins to interact with other 
actin-binding proteins, including blocking actin severing by ADF/cofilin (Skau & 
Kovar, 2010), or associating with formin-nucleated actin filaments (Johnson et al., 
2014). 
In our proposed model, the “closed” tropomyosin-actin state differentially 
regulates actomyosin.  Consistent with this model, the “closed” Cdc8-actin state 
prevents myosin I binding (Clayton et al., 2010), while the same filament activates 
Myo52 and Myo2.  Although the tropomyosin-actin state of Tpm3.1 and Tpm4.2 has 
not yet been determined, our results indicate that these two tropomyosin isoforms 
regulate myosin in a manner similar to the “closed” state observed with Cdc8.  The 
differential regulation of actomyosin by non-muscle tropomyosins described in these 
studies has broad implications to the sorting of myosin motors to specific actin 
structures and can potentially play an important role in the regulation of actomyosin 
processes in higher eukaryotes.  
   
Future Directions 
The duty ratio of the non-processive type V myosin in budding yeast is 
increased by a tropomyosin-induced decrease in the ADP release rate. Conducting 
transient kinetics studies on fission yeast Myo52 will help determine if tropomyosin 
also decreases the ADP release rate of this type V motor.  Additionally, understanding 
the molecular mechanism of Myo52 regulation by tropomyosin – as well as the 
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regulation of non-muscle type II myosins – depends largely on generating high 
resolution models of these motors in complex with tropomyosin decorated actin 
filaments. 
A likely important factor in the differential regulation of myosin motors by 
tropomyosin is the overlapping tropomyosin N- and C-termini (Moraczewska et al., 
2000; Palm et al., 2003).  Appendix A describes a preliminary evaluation of type II 
myosin regulation by tropomyosin that focuses on the role of the tropomyosin C-
terminus.  This study demonstrates differential regulation of type II non-muscle myosin 
(Myo2) that is tropomyosin isoform dependent.  Furthermore, there is evidence of a 
correlation between the C-terminal sequence of a given tropomyosin isoform and its 
ability to positively regulate Myo2.  However, repeating these experiments, as well as 
expanding them to include other tropomyosin isoforms, will be required to draw 
conclusions from this preliminary study.  Furthermore, all the experiments to date have 
been performed using skeletal actin.  Thus, it is critical to investigate the role actin 
isoforms play in determining the ability of tropomyosin to regulate myosin needs to be 
investigated.  
 Building on the differential regulation of myosin by mammalian tropomyosin 
isoforms described above and in appendix A, it will be valuable to explore the 
importance of specific regions of tropomyosin in regulating other actin binding proteins.  
Tropomyosin has been shown to affect actin severing by cofilin in yeast (Skau & 
Kovar, 2010) and mammals (Bryce et al., 2003).  However, the mechanism of this 
regulation is not known.  Focusing on the role of tropomyosin N- and C-termini in 
blocking actin severing by cofilin could provide valuable insight into the regulation of 
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actin structures by tropomyosin in normal and diseased cells.   
Tm3.1 is the predominant low molecular weight tropomyosin isoform expressed 
in primary tumors and tumor cell lines.  Levels of Tm3.1 are elevated in transformed 
neuroblastoma and melanoma cell lines compared to representative primary and 
immortalized cell lines (Stehn et al., 2013).  Small molecules that target Tpm3.1 
(ATMs) have been developed using in silico modeling to identify molecules capable of 
binding to the C-terminal pocket of Tm3.1. Treatment of neuroblastoma cells with 
ATMs disrupts Tm3.1 containing actin filaments in a dose-dependent manner, reverting 
the actin cytoskeleton back to a pre-transformed state while having minimal effect on 
normal cells (Stehn et al., 2013). The application of ATMs as anticancer therapeutics 
will require efficient screening for compounds that effectively disrupt Tpm3.1, as well 
as determining the mechanism through which this disruption occurs.  Fission yeast cells 
requiring Tpm3.1 for viability potentially provide a unique high-throughput system to 





Figure 4-1. Three-dimensional reconstructions of negatively stained actin 
filaments. Surface views of reconstructions of (A) F-actin control filaments (actin 
subdomains 1 to 4 marked on one actin monomer) and (B,C) F-actin-Cdc8. Additional 
density corresponding to tropomyosin (arrows) is observed for the filaments 
containing Cdc8. Cdc8 occupies the `closed' position on actin, i.e. it localizes on the 
outer edge of actin subdomains 3 and 4 next to the cleft separating the inner 
(subdomains 3 and 4) and outer (subdomains 1 and 2) domains of actin, which is the 
same position previously described for troponin-tropomyosin-regulated filaments in 
the absence of Ca2+ by Lehman et al., 1994.  (Modified and used, with permission, 
from Skoumpla et al. Journal of Cell Science, 2007)  
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 APPENDIX A:  TROPOMYOSIN ISOFORM DEPENDENT REGULATION OF 
TYPE II MYOSIN 
 
Introduction 
The actin cytoskeleton facilitates a variety of processes in eukaryotic cells, including 
cargo transport, cell motility, membrane remodeling, and division.  These processes 
depend upon diverse actin structures – cables, stress fibers, membrane patches, and the 
mitotic ring – interacting with specific myosin motors (dos Remedios et al., 2003; 
Fanning et al., 1994; Murrell et al., 2015). Given the large number of myosin subtypes 
operating in close proximity to one another, establishing and maintaining the specificity 
of these actomyosin interactions presents a challenge to eukaryotic cells. The 
tropomyosin family of proteins has been identified as playing a critical role in this 
process, although it remains unclear how the ~40 identified mammalian tropomyosin 
isoforms accomplish this task (Clayton et al., 2015; Clayton et al., 2014; Clayton et al., 
2010; Gunning, Hardeman, et al., 2015). 
The importance of non-muscle tropomyosins has recently been highlighted by a 
growing appreciation of their involvement in multiple types of metastatic cancers 
(Lopez et al., 2008; H. Yamaguchi et al., 2007). A characteristic shift has been 
identified in the tropomyosin expression profile of melanoma and neuroblastoma cells 
(Stehn et al., 2013). The mechanism of tropomyosin involvement in metastatic cells is 
not clear, though a new class of cancer therapeutics is being developed to target specific 
tropomyosins (Stehn et al., 2013). Identifying the determining factors behind the 
differential ability of tropomyosin isoforms to regulate myosin function is critical to 
understanding their role in normal and disease cellular processes.  
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Tropomyosins are a family of alpha helical proteins that form coiled coil parallel 
dimers that self assemble into filaments in a head to tail fashion, through the 
overlapping N- and C-termini of adjacent molecules.  Unlike the high actin affinity of 
many actin binding proteins, tropomyosin filaments form weak ionic interactions along 
the large helical groove of filamentous actin (F-actin) (Hitchcock-DeGregori, 2008). 
Four mammalian tropomyosin genes, TPM1-4, produce over forty isoforms by alternate 
splicing exons one through nine. Tropomyosin isoforms containing exon 1a and either 
2a or 2b are termed high molecular weight, with approximately 284 amino acids and 
covering seven actin subunits. Low molecular weight tropomyosin isoforms contain 
exon 1b and consist of approximately 248 amino acids covering six actin subunits 
(Hitchcock-DeGregori, 2008). All tropomyosin isoforms contain one exon nine variant, 
9a, 9b, 9c, or 9d (Gooding & Smith, 2008; Vrhovski et al., 2008).  
Tropomyosin isoforms that follow tissue specific expression are categorized as:  
brain-, smooth muscle-, and or striated muscle-specific.  The remaining isoforms are 
referred to collectively as cytoplasmic. Multiple tropomyosin isoforms are expressed 
concurrently in mammalian cells but localize to distinct actin structures (Bryce et al., 
2003). The mechanisms involved in establishing and maintaining these different actin-
tropomyosin populations is not entirely known, though recent evidence points to the 
actin-nucleating family of proteins (e.g. formins and Arp2/3) as playing an important 
role in the process (Johnson et al., 2014; Tojkander et al., 2011).  
The ability of tropomyosins to regulate myosin motor function in contractile 
muscle systems has been well characterized (Gordon et al., 2000). However, much less 
is known about the role of tropomyosin in regulating the large number of non-muscle 
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myosins (Gunning et al., 2005).  Fission yeast has proven to be a powerful model 
organism in which to study the effect of tropomyosin on non-muscle myosins due to the 
organism’s highly tractable genetics and relatively simple cytoskeleton.  The sole 
fission yeast tropomyosin, Cdc8, is restricted to the mitotic ring and actin cables, where 
it promotes the contractile activity of the type II non-muscle myosin, Myo2 
(Balasubramanian et al., 1992; Stark et al., 2010), and cargo transport by the type-V 
myosin, Myo52 (Clayton et al., 2014). Conversely, the presence of Cdc8 at these two 
actin structures inhibits the association of the type-I myosin, Myo1, limiting its function 
to the actin patches responsible for membrane remodeling (Clayton et al., 2010; Skau & 
Kovar, 2010).   
Previously we used the fission yeast system to evaluate the ability of 
mammalian tropomyosin isoforms to regulate non-muscle myosins (Chapter 3) (Clayton 
et al., 2015). We demonstrated that decoration of actin filaments by two cancer 
associated low-molecular weight tropomyosin isoforms, Tpm3.1 or Tpm4.2, enhanced 
the actin-dependent ATPase and actin filament gliding activity of Myo2 and Myo52, 
while inhibiting skeletal muscle myosin II (SKMM-II). These tropomyosins did not 
significantly affect the chick brain type-V myosin MyoVa (Clayton et al., 2015). Our 
findings demonstrate a myosin isoform dependent level of differential regulation by 
tropomyosin, in which for a given myosin, all tropomyosins tested show a similar 
behavior. Although Tpm3.1 and Tpm4.2 are produced from different genes and 
therefore do not consist of identical sequences, both are products of the same exon 
arrangement – specifically, both contain exons 1b, 6b, and 9d from their respective 
gene. Given the large cast of mammalian tropomyosin isoforms produced through 
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alternate exon arrangements, it seems highly unlikely that all isoforms would behave 
the same with respect to regulating myosin.   
The N- and C-termini have been identified as playing an important role in 
defining how skeletal muscle tropomyosins interact with both actin and myosin (Palm et 
al., 2003).  Therefore, in this study we focus on the role of sequence differences in 
tropomyosin terminal exons (1 and 9) in regulating Myo2p.  Four non-muscle 
tropomyosin isoforms from the TPM1 gene were selected to assess the role of the 
overlapping N- and C-termini in the regulation of Myo2p activity using actin activated 
ATPase assays. The tropomyosin panel consists of one pair of low molecular weight 
isoforms, Tpm1.8 and Tpm1.12, and one pair of high molecular weight isoforms, 
Tpm1.6 and Tpm1.10.  Each member of a given pair has an identical N-terminus – 
derived from either exon 1a or 1b, for high and low molecular weight, respectively.  
The C-terminus of Tpm1.12 and Tpm1.10 contain exon 9c, while Tpm1.8 and Tpm1.6 
contain exon 9d. Preliminary findings indicate that the particular coupling of N- and C-
termini sequences appears to be an important determinant in the ability of mammalian 
tropomyosin isoforms to differentially regulate Myo2p.  
 
Results 
Previously it was demonstrated that Tpm3.1 and Tpm4.2 – tropomyosin isoforms 
expressed from two different genes, though sharing the same exon arrangement – 
showed a similar Myo2 regulation (Chapter 3) (Clayton et al., 2015).  Here we 
identified two sets of tropomyosin isoforms from TPM1 identical to one another except 
at exon 9 (Figure A-1). Tpm1.6 and Tpm1.10 are both high molecular weight isoforms 
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containing exon 1a. The C-terminus of Tpm1.6 is encoded by exon 9d while the C-
terminus of Tpm1.10 is encoded by exon 9c. Similarly, the low molecular weight 
Tpm1.8 and Tpm1.12 derive from exon 1b, with Tpm1.8 containing exon 9d while 
Tpm1.12 is derived from exon 9c.   
The ATPase activity of myosin is coupled to its binding to F-actin.  Therefore 
the activity of Myo2 in solution with F-actin and Mg2+-ATP can be determined under 
varying conditions by measuring the production of inorganic phosphate (Pi) over time. 
To measure the effect of different tropomyosin isoforms on Myo2 activity in this 
system, actin was polymerized in the presence of tropomyosin at a ratio of 2:1 for 30 
minutes. Myo2 activity was determined by measuring the production of Pi over a thirty-
minute reaction with 1, 2, 5, 10 and 30 mM of undecorated F-actin or F-actin and 
tropomyosin, using a standard Malachite green assay. The results from three 
independent experiments were plotted and fitted with an exponential curve following 
Michaelis-Menten kinetics. This assumption has been validated in previous experiments 
and allows to determine Myo2 kinetics (Stark et al., 2010). Tpm1.8 significantly 
increased Myo2 ATPase activity over undecorated actin, similar to that achieved with 
actin decorated with Cdc8p.  In contrast, Tpm1.12 did not significantly alter Myo2p 
ATPase activity (Figure A-2a).  Tpm1.6 and Tpm1.10 both slightly increased Myo2p 
ATPase activity compared to undecorated actin, though considerably less than Cdc8p 
(Figure A-2b). Michaelis-Menten kinetics and Myo2p efficiency can be derived from 
the ATPase graphs (Table A-1).  Actin decorated with Tpm1.8 resulted in over a two-
fold increase in Myo2 Vmax and over a four-fold reduction in KM compared to 
undecorated actin. These results are comparable to those previously observed with 
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Tpm3.1, Tpm4.2, and Cdc8 (Clayton et al., 2015; Stark et al., 2010). In contrast, the 
exon 9c derived Tpm1.12 did not significantly alter the Vmax or Km of Myo2p. The high 
molecular weight TPM1 isoforms, Tpm1.6 and Tpm1.10, behaved nearly identically to 
one another, resulting in a slight, but significant, increase in Myo2 Vmax and over a four 
fold reduction in KM relative to undecorated actin.  
 
Discussion 
Tropomyosin isoforms demonstrate varying abilities to regulate myosin activity. 
Four TPM1 isoforms were selected for this study to evaluate the role of sequence 
variations in the tropomyosin C-terminus in the context of two different N-termini 
sequences. Since the sequences of the tropomyosin isoforms being compared are 
identical up to the terminal exon, any differences in actomyosin regulation resulting 
within these tropomyosin pairs can be strictly attributed to changes induced by the C-
terminus (Figure A-3).  
The comparison of the low-molecular weight tropomyosin isoforms Tpm1.8 and 
Tpm1.12 shows that a C-terminus derived from exon 9d is able to activate Myo2 while 
a C-terminus derived from exon 9c is not. These differences could be explained 
mechanistically by direct interactions between myosin and the C-terminus of 
tropomyosin, and/or tropomyosin C-terminus dependent changes to actin that affect 
myosin binding. However, when two tropomyosin isoforms with a different N-terminus, 
Tpm1.6 and Tpm1.10, are compared, the same respective 9c and 9d C-terminal 
sequences do not affect Myo2 regulation.  Thus, it appears that both the N- and the C-
termini are responsible for determining the ability of tropomyosin to regulate Myo2. 
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The particular pairing of overlapping N- and C-termini may induce allosteric effects 
along the length of the tropomyosin filament. In this case, a tropomyosin filament built 
on interactions between the exon 9d derived C-terminus with the exon 1b encoded N-
terminus results in a conformation that activates Myo2.  In stark contrast, Myo2 
activation is not achieved by a tropomyosin filament conformation in which the exon 9c 
derived C-terminus overlaps with the exon 1b derived N-terminus.  
A preliminary experiment comparing two low-molecular tropomyosin isoforms 
from TPM3, Tpm3.1 and Tpm3.7, indicates that the exon 9d derived Tpm3.1 activated 
Myo2 as previously described (Clayton et al., 2015). Interestingly though, the exon 9c 
derived Tpm3.7 also slightly increased Myo2 activity over undecorated actin (data not 
shown).  Although this experiment needs to be repeated, it could be explained by 
sequence differences between the TPM3 9c and TPM1 9c exons.  
We conducted a sequence alignment of the overlapping N- and C-terminal 
regions of each of the tropomyosin isoforms included in this study to identify any 
obvious residues responsible for the observed effects on Myo2 activity (Figure A-4).  
The first 25 amino acids of the N-terminal and C-terminal sequences of each of the 
tropomyosin isoforms were included in the alignment. Exon sequences have high 
similarity across genes (i.e., TPM1 1a vs. TPM3 1a; and TPM1 1b vs TPM3 1b), 
however sequences vary considerably between different exons of the same gene (i.e., 
TPM1 1a vs. TPM1 1b; and TPM3 1a vs. TPM3 1b).  In the future, these alignments 
can be used to generate models of the tropomyosin-actin copolymer for each 
tropomyosin isoform.   These models will add valuable insight to understanding the 
structural mechanism underlying differential regulation of myosin by tropomyosin.  
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Additionally, it would be informative to test tropomyosin chimeras constructed by 
systematically swapping-in only the ten to twelve overlapping residues at the N- and C-
termini into one of the isoforms in this study and measuring the effect on Myo2 ATPase 
activity.  However, it remains likely that in addition to sequence differences at the N- 
and C-termini, short sequence variations throughout the length of tropomyosins 
contribute to differing abilities of isoforms to activate Myo2 and should also be 
investigated further.  
In summary, we have described a tropomyosin isoform dependent level of 
differential regulation of myosin.  The tropomyosin N- and C-termini determine, at least 
partially, the regulatory effect on the type II non-muscle myosin Myo2. This work 
improves our understanding of how eukaryotic cells are able to establish and maintain 
specific myosin motor behavior at diverse actin structures. 
  
Materials and Methods 
Bacterial plasmid expression 
Rattus Norvegious tropomyosin isoform cDNA was generously provided by 
Sarah Hitchcock-DeGregori (Tpm1.6, Tpm1.8 and Tpm1.10) and Peter Gunning 
(Tpm3.12). Tropomyosin constructs were cloned into pET-3 vectors as previously 
described and confirmed by DNA sequencing completed by the DNA Analysis Facility 
at UVM.  Briefly, Tpm1.6 was PCR amplified from cDNA using the following primers: 
5’ CATATGGCGTCGATGCACGCCAT- CAAGAAGAAGATGCAG (the Nde1 site 
is italicized, the Ala-Ser acetylation mimic is in bold, and the start codon is underlined), 
and 3’ GGATCCTTAATCCTCA-TTCAGGGCCAGC (the BamH1 site is italicized and 
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the stop codon is underlined). Tropomyosin-pET-3 vectors were subsequently cloned in 
BL21 Escherichia coli cells. Tpm1.8, Tpm1.10, and Tpm1.12 were cloned in an 
identical manner. 
 
Actin expression and purification 
Actin was purified from acetone powder derived from chicken pectoral muscle 
as previously described (Spudich & Watt, 1971).  Briefly, acetone powder was 
dissolved in 20 mL/g G-buffer (2mM Tris-Cl pH 8.0, 0.2mM ATP, 0.5mM DTT, 
0.1mM CaCL2, 1mM NaAzide) at 4oC to release actin.  After 30 minutes the suspension 
was subjected to centrifugation for 30 minutes at 25,000 RCF and the supernatant was 
filtered using glass wool.  The pellet was resuspended in original volume of G-buffer 
and steps two and three were repeated to extract the remaining actin.  KCl and MgCl2 
were added to the pooled supernatants from previous steps to bring the concentrations 
to 50mM and 2mM, respectively, enabling actin polymerization. After one hour, actin 
associated proteins were released from the actin in suspension by the addition of KCl to 
0.8M.  Following a 30 min incubation, actin was pelleted by centrifugation at 200,000 
RCF for 90 minutes.  Actin pellets were rinsed with G-buffer before homogenization in 
3mL G-buffer/gram of acetone powder used. Aliquots of G-actin were flash frozen in 
liquid nitrogen and stored at -80o C for later use. 
 
Tropomyosin expression and purification 
BL21 e. coli cells transformed with tropomyosin plasmids were grown in 
Lysogeny Broth at 37o C to OD600 0.8. Tropomyosin expression was induced by 
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addition of 0.4mM Isopropyl β-D-1-thiogalactopyranoside to BL21 cultures. Twelve 
hours at 25o C after induction, cells were pelleted by centrifugation at 18,000 RCF for 
30 minutes.  Pelleted cells were resuspended in lysis buffer (100 mM NaCl, 10 mM 
imidazole, pH 7.2, 2 mM EDTA, and 1 mM DTT) and lysed by tip sonication.  Lysed 
cells were then boiled for 10 minutes and subjected to centrifugation for 15 minutes at 
45,000 RCF.  Tropomyosin was subsequently precipitated out of the collected 
supernatants by reducing the pH to 0.2 units below the isoelectric point of the respective 
tropomyosin (e.g. pH 4.2 for Tpm1.12) and pelleted by centrifugation for 15 minutes at 
45,000 RCF.  Tropomyosin pellets were resuspended in Tpm buffer (50 mM NaCl, 1 
mM DTT, 10 mM imidazole (pH 7.4)) and dialyzed 3 times against 1 L of Tpm buffer.  
Aliquots of tropomyosin were flash frozen in liquid nitrogen and stored at -80o C for 
later use. 
 
Myo2p expression and purification 
Full-length Myo2p heavy chain and GST- tagged light chains were over-
expressed in fission yeast cells and purified as previously described (Lord & Pollard, 
2004).  Briefly, fission yeast cultures were grown in Edinburgh Minimal Media (EMM) 
plus 20 mg/mL thiamine overnight to OD595 2.0. Cultures were subsequently diluted in 
EMM minus thiamine to OD595 0.05 and allowed to grow at 30oC for 24 hours.  Cells 
were harvested by centrifugation at 2000 RCF for 10 minutes. Cell pellets were 
resuspended in 10 mL/1L culture in Lysis buffer (750mM KCl, 25mM Tris-HCl, pH 
7.4, 4mM MgCl2, 20mM Na4P2O7, 2mM EGTA, 0.1% Triton X-100, 1mM DTT, 
2mM PMSF, 4mM ATP, 2mM Benzamidine) and lysed using a Fastprep bead-beater 
155	  	  
(MP Biochemicals).  Beads were removed by low-speed centrifugation and the 
collected lysate was subjected to centrifugation at 100,000 RCF for 45 minutes.  The 
supernatant was incubated for 2 hours with 0.4 mL glutathione-Sepharose (Amersham 
Biosciences) per liter of the original culture and placed into an empty column.  After 
allowing the lysate to flow through the column, the glutathione-Sepharose resin bed was 
washed with 10 column volumes of Lysis buffer.  Bound GST tagged light chains and 
associated heavy chains were eluted by addition of Lysis buffer plus 100mM 
glutathione.  Pooled elution fractions were dialyzed 3 times against 1 L of A15 Buffer 
(500mM KCl, 10mM Imidazole (pH7.2), 0.4mM NaN3, 1.0mM DTT, 50% glycerol) 
and stored at 4o C for later use.  
 
Actin-activated ATPase assay  
Myo2 activity was measured using a standard F-actin dependent Malachite green 
ATPase assay to quantify Pi release as previously described. Briefly, all assays were 
conducted at room temperature with 30nM Myo2p in 2 mM Tris-HCl, 10 mM 
imidazole, pH 7.2, 60 mM KCl, 0.1 mM CaCl2, 3 mM MgCl2, 2 mM ATP, and 1 mM 
DTT.  Actin filaments were pre-incubated with tropomyosin at a 2:1 ratio for 30 
minutes and added to the assay at 1, 2, 5, 10 or 30mM.  Reactions were initiated by the 
addition of 2mM Mg+-ATP and quenched after 30 minutes by the addition of 32% 
sodium citrate. Three independent experiments were conducted and fit to Michaelis-
Menten kinetics using Graphpad Prism 6.  
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Table A-1. Myo2 Vmax, Km (µM) (mean ± SD) and catalytic efficiency 





Actin track Myo2 Vmax (S-1) Myo2 Km (µM) Catalytic  
Efficiency 
Actin- 1.1 ± 0.1 11.2 ± 1.8 0.1 
Actin-Cdc8p 2.0 ± 0.1 1.0 ± 0.1 2.0 
Actin-Tpm1.6  1.5 ± 0.1 2.4 ± 0.7 0.6 
Actin-Tpm1.10  1.3 ± 0.1 2.4 ± 0.4 0.5 
Actin-Tpm1.8  2.4 ± 0.1 2.6 ± 0.4 0.9 





Figure A-1. Schematic summary of exon usage by mammalian tropomyosin 
isoforms from the TPM1 gene included in this study. A panel of four TPM1 
gene products were selected based on differences at the N- and C-termini. 
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Figure A-2. Differential regulation of Myo2p actin-activated ATPase activity by 
non-muscle tropomyosin.  Standard Malachite green actin dependent ATPase assays 
were used to compare the ability of tropomyosin isoforms to regulate Myo2p activity. 
(A) Comparison of two low-molecular weight tropomyosin isoforms, Tpm1.8 and 
Tpm1.12. (B) Comparison of two high-molecular weight tropomyosin isoforms, 
Tpm1.6 and Tpm1.10. Cdc8p and undecorated values were standardized across both 
graphs.  Values from three independent rounds were fit to Michaelis-Menten kinetics 


























Figure A-3.  Relationship between tropomyosin termini and Myo2 regulation.  
Cartoon of tropomyosin protein N- to C-terminal overlap for isoforms included in 




Figure 4. Alignment of overlapping N- and C-termini regions from tropomyosin 
isoforms included in this study.  Protein sequence alignments were performed using 
the Clustal Omega program by EMBL-EBI.  Alignment results were used to construct 
sequence overlap models of the first ten amino acids of the N-termini and the last ten 
amino acids from the C-termini of tropomyosin isoforms.  These models can be used to 
identify sequence differences between tropomyosin isoforms that may contribute to 
variable levels of Myo2 enhancement.   
 
